{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T22:16:12Z","timestamp":1795126572496,"version":"4.10.3"},"reference-count":423,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["AR075735"],"award-info":[{"award-number":["AR075735"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["DE023813"],"award-info":[{"award-number":["DE023813"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["AR070135"],"award-info":[{"award-number":["AR070135"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["AG056438"],"award-info":[{"award-number":["AG056438"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Discov"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Osteoclasts are bone-resorbing cells that play a central role in normal bone remodeling and contribute to bone loss associated with pathological conditions such as osteoporosis, osteoarthritis, rheumatoid arthritis, periodontal disease, and bone metastases of cancer. The commitment, differentiation, and function of osteoclasts depend on the establishment of specific gene expression patterns orchestrated through a network of transcription factors, which are sequentially activated by osteoclastogenic signals. This review provides an updated overview of the roles of key signaling pathways (e.g., RANKL signaling, NF-\u03baB signaling and G\u03b1\n                    <jats:sub>13<\/jats:sub>\n                    signaling), transcription factors (e.g., PU.1, C\/EBP-\u03b1, NFATc1 and IRF8), cytokines (e.g., TNF-\u03b1, IL-1\u03b2 and IL-6), and epigenetic regulators (e.g., DNMT3a, EZH2 and ASXL1) in osteoclast lineage commitment, differentiation and bone resorption under both physiological and pathological inflammatory conditions, along with insights from corresponding mouse models. We described the mechanism by which osteoclast-mediated bone resorption occurs through extracellular acidification driven by osteoclast-specific proton pump subunits (e.g., ATP6i and ATP6v0d2), followed by matrix protein degradation mediated by cathepsin K and MMP-9. Additionally, this review examines the interplay among molecular mechanisms that regulate osteoclast differentiation and activation under pathological and inflammatory conditions, elucidates their roles in osteoclast hyperactivation-related human diseases, and provides a comprehensive framework for understanding these processes. Finally, it underscores potential novel therapeutic strategies for osteoclast-related skeletal lytic diseases and highlights perspectives for future investigations.\n                  <\/jats:p>","DOI":"10.1038\/s41421-025-00853-6","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T16:03:37Z","timestamp":1768925017000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Cell signaling and transcriptional regulation of osteoclast lineage commitment, differentiation, bone resorption and diseases"],"prefix":"10.1038","volume":"12","author":[{"given":"Siyu","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Qi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alasdair","family":"Masson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2188-6958","authenticated-orcid":false,"given":"Yi-Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"853_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2005.10.028","volume":"367","author":"J Rubin","year":"2006","unstructured":"Rubin, J., Rubin, C. & Jacobs, C. R. Molecular pathways mediating mechanical signaling in bone. Gene 367, 1\u201316 (2006).","journal-title":"Gene"},{"key":"853_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0171-2985(82)80074-0","volume":"161","author":"JF Loutit","year":"1982","unstructured":"Loutit, J. F. & Nisbet, N. W. The origin of osteoclasts. Immunobiology 161, 193\u2013203 (1982).","journal-title":"Immunobiology"},{"key":"853_CR3","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1172\/JCI200419657","volume":"114","author":"F Ikeda","year":"2004","unstructured":"Ikeda, F. et al. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J. Clin. Invest. 114, 475\u2013484 (2004).","journal-title":"J. Clin. Invest."},{"key":"853_CR4","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1196\/annals.1402.071","volume":"1116","author":"H Takayanagi","year":"2007","unstructured":"Takayanagi, H. The role of NFAT in osteoclast formation. Ann. N. Y. Acad. Sci. 1116, 227\u2013237 (2007).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"853_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5152\/eurjrheum.2016.048","volume":"4","author":"T S\u00f6zen","year":"2017","unstructured":"S\u00f6zen, T., \u00d6z\u0131\u015f\u0131k, L. & Ba\u015faran, N. An overview and management of osteoporosis. Eur. J. Rheumatol. 4, 46\u201356 (2017).","journal-title":"Eur. J. Rheumatol."},{"key":"853_CR6","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/125705","volume":"2013","author":"MN Weitzmann","year":"2013","unstructured":"Weitzmann, M. N. The role of inflammatory cytokines, the RANKL\/OPG axis, and the immunoskeletal interface in physiological bone turnover and osteoporosis. Scientifica 2013, 125705 (2013).","journal-title":"Scientifica"},{"key":"853_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jphs.2022.10.007","volume":"151","author":"Y Otsuka","year":"2023","unstructured":"Otsuka, Y. et al. IL-1\u03b2 promotes osteoclastogenesis by increasing the expression of IGF2 and chemokines in non-osteoclastic cells. J. Pharm. Sci. 151, 1\u20138 (2023).","journal-title":"J. Pharm. Sci."},{"key":"853_CR8","doi-asserted-by":"publisher","first-page":"116540","DOI":"10.1016\/j.bone.2022.116540","volume":"164","author":"P Zhou","year":"2022","unstructured":"Zhou, P., Zheng, T. & Zhao, B. Cytokine-mediated immunomodulation of osteoclastogenesis. Bone 164, 116540 (2022).","journal-title":"Bone"},{"key":"853_CR9","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1182\/blood-2005-12-008763","volume":"108","author":"D Wang","year":"2006","unstructured":"Wang, D., D\u2019Costa, J., Civin, C. I. & Friedman, A. D. C\/EBPalpha directs monocytic commitment of primary myeloid progenitors. Blood 108, 1223\u20131229 (2006).","journal-title":"Blood"},{"key":"853_CR10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.4161\/org.25676","volume":"9","author":"CV Jones","year":"2013","unstructured":"Jones, C. V. & Ricardo, S. D. Macrophages and CSF-1: implications for development and beyond. Organogenesis 9, 249\u2013260 (2013).","journal-title":"Organogenesis"},{"key":"853_CR11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.bone.2017.05.009","volume":"107","author":"J Jules","year":"2018","unstructured":"Jules, J., Li, Y. P. & Chen, W. C\/EBP\u03b1 and PU.1 exhibit different responses to RANK signaling for osteoclastogenesis. Bone 107, 104\u2013114 (2018).","journal-title":"Bone"},{"key":"853_CR12","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s12276-024-01157-7","volume":"56","author":"N Takegahara","year":"2024","unstructured":"Takegahara, N., Kim, H. & Choi, Y. Unraveling the intricacies of osteoclast differentiation and maturation: insight into novel therapeutic strategies for bone-destructive diseases. Exp. Mol. Med. 56, 264\u2013272 (2024).","journal-title":"Exp. Mol. Med."},{"key":"853_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.788680","volume":"9","author":"Y Sun","year":"2021","unstructured":"Sun, Y. et al. Recent advances in osteoclast biological behavior. Front. Cell Dev. Biol. 9, 788680 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"853_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s10020-024-00788-w","volume":"30","author":"H Zheng","year":"2024","unstructured":"Zheng, H. et al. Recent advances of NFATc1 in rheumatoid arthritis-related bone destruction: mechanisms and potential therapeutic targets. Mol. Med. 30, 20 (2024).","journal-title":"Mol. Med."},{"key":"853_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1146\/annurev-pathmechdis-031521-040919","volume":"18","author":"DJ Veis","year":"2023","unstructured":"Veis, D. J. & O\u2019Brien, C. A. Osteoclasts, master sculptors of bone. Annu. Rev. Pathol. 18, 257\u2013281 (2023).","journal-title":"Annu. Rev. Pathol."},{"key":"853_CR16","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1056\/NEJM198003273021301","volume":"302","author":"PF Coccia","year":"1980","unstructured":"Coccia, P. F. et al. Successful bone-marrow transplantation for infantile malignant osteopetrosis. N. Engl. J. Med. 302, 701\u2013708 (1980).","journal-title":"N. Engl. J. Med."},{"key":"853_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.664871","volume":"12","author":"Y Yao","year":"2021","unstructured":"Yao, Y. et al. The macrophage-osteoclast axis in osteoimmunity and osteo-related diseases. Front. Immunol. 12, 664871 (2021).","journal-title":"Front. Immunol."},{"key":"853_CR18","first-page":"363","volume":"122","author":"R Baron","year":"1986","unstructured":"Baron, R., Neff, L., Tran Van, P., Nefussi, J. R. & Vignery, A. Kinetic and cytochemical identification of osteoclast precursors and their differentiation into multinucleated osteoclasts. Am. J. Pathol. 122, 363\u2013378 (1986).","journal-title":"Am. J. Pathol."},{"key":"853_CR19","doi-asserted-by":"publisher","first-page":"87S","DOI":"10.1016\/8756-3282(95)00185-G","volume":"17","author":"T Suda","year":"1995","unstructured":"Suda, T., Udagawa, N., Nakamura, I., Miyaura, C. & Takahashi, N. Modulation of osteoclast differentiation by local factors. Bone 17, 87S\u201391S (1995).","journal-title":"Bone"},{"key":"853_CR20","doi-asserted-by":"publisher","unstructured":"Novack, D. V. & Mbalaviele, G. Osteoclasts-key players in skeletal health and disease. Microbiol. Spectr. 4, https:\/\/doi.org\/10.1128\/microbiolspec.MCHD-0011-2015 (2016).","DOI":"10.1128\/microbiolspec.MCHD-0011-2015"},{"key":"853_CR21","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/ar.1092140413","volume":"214","author":"BA Scheven","year":"1986","unstructured":"Scheven, B. A., Kawilarang-De Haas, E. W., Wassenaar, A. M. & Nijweide, P. J. Differentiation kinetics of osteoclasts in the periosteum of embryonic bones in vivo and in vitro. Anat. Rec. 214, 418\u2013423 (1986).","journal-title":"Anat. Rec."},{"key":"853_CR22","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1359\/jbmr.1999.14.4.487","volume":"14","author":"YP Li","year":"1999","unstructured":"Li, Y. P. & Chen, W. Characterization of mouse cathepsin K gene, the gene promoter, and the gene expression. J. Bone Min. Res. 14, 487\u2013499 (1999).","journal-title":"J. Bone Min. Res."},{"key":"853_CR23","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202409169","volume":"224","author":"O Dufrancais","year":"2025","unstructured":"Dufrancais, O. et al. Moesin controls cell-cell fusion and osteoclast function. J. Cell Biol. 224, e202409169 (2025).","journal-title":"J. Cell Biol."},{"key":"853_CR24","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1093\/jbmr\/zjae125","volume":"39","author":"M Barnea-Zohar","year":"2024","unstructured":"Barnea-Zohar, M. et al. SNX10 regulates osteoclastogenic cell fusion and osteoclast size in mice. J. Bone Min. Res. 39, 1503\u20131517 (2024).","journal-title":"J. Bone Min. Res."},{"key":"853_CR25","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.93457","volume":"13","author":"T Gilbert","year":"2024","unstructured":"Gilbert, T. et al. Loss of ninein interferes with osteoclast formation and causes premature ossification. Elife 13, e93457 (2024).","journal-title":"Elife"},{"key":"853_CR26","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/jbmr.5650090415","volume":"9","author":"AL Wucherpfennig","year":"1994","unstructured":"Wucherpfennig, A. L., Li, Y. P., Stetler-Stevenson, W. G., Rosenberg, A. E. & Stashenko, P. Expression of 92 kD type IV collagenase\/gelatinase B in human osteoclasts. J. Bone Min. Res. 9, 549\u2013556 (1994).","journal-title":"J. Bone Min. Res."},{"key":"853_CR27","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1002\/jbmr.5650100809","volume":"10","author":"YP Li","year":"1995","unstructured":"Li, Y. P. et al. Cloning and complete coding sequence of a novel human cathepsin expressed in giant cells of osteoclastomas. J. Bone Min. Res. 10, 1197\u20131202 (1995).","journal-title":"J. Bone Min. Res."},{"key":"853_CR28","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1083\/jcb.99.6.1901","volume":"99","author":"EH Burger","year":"1984","unstructured":"Burger, E. H., van der Meer, J. W. & Nijweide, P. J. Osteoclast formation from mononuclear phagocytes: role of bone-forming cells. J. Cell Biol. 99, 1901\u20131906 (1984).","journal-title":"J. Cell Biol."},{"key":"853_CR29","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1210\/endo-123-5-2600","volume":"123","author":"N Takahashi","year":"1988","unstructured":"Takahashi, N. et al. Osteoblastic cells are involved in osteoclast formation. Endocrinology 123, 2600\u20132602 (1988).","journal-title":"Endocrinology"},{"key":"853_CR30","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1359\/jbmr.1998.13.7.1112","volume":"13","author":"W Chen","year":"1998","unstructured":"Chen, W. & Li, Y. P. Generation of mouse osteoclastogenic cell lines immortalized with SV40 large T antigen. J. Bone Min. Res. 13, 1112\u20131123 (1998).","journal-title":"J. Bone Min. Res."},{"key":"853_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/978-1-59745-104-8_2","volume":"455","author":"EW Bradley","year":"2008","unstructured":"Bradley, E. W. & Oursler, M. J. Osteoclast culture and resorption assays. Methods Mol. Biol. 455, 19\u201335 (2008).","journal-title":"Methods Mol. Biol."},{"key":"853_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41556-019-0437-8","volume":"22","author":"Y Yahara","year":"2020","unstructured":"Yahara, Y. et al. Erythromyeloid progenitors give rise to a population of osteoclasts that contribute to bone homeostasis and repair. Nat. Cell Biol. 22, 49\u201359 (2020).","journal-title":"Nat. Cell Biol."},{"key":"853_CR33","doi-asserted-by":"publisher","first-page":"148","DOI":"10.4161\/cam.20888","volume":"6","author":"K Matsuo","year":"2012","unstructured":"Matsuo, K. & Otaki, N. Bone cell interactions through Eph\/ephrin: bone modeling, remodeling and associated diseases. Cell Adh. Migr. 6, 148\u2013156 (2012).","journal-title":"Cell Adh. Migr."},{"key":"853_CR34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/03008207.2017.1290085","volume":"59","author":"X Chen","year":"2018","unstructured":"Chen, X. et al. Osteoblast-osteoclast interactions. Connect. Tissue Res. 59, 99\u2013107 (2018).","journal-title":"Connect. Tissue Res."},{"key":"853_CR35","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1177\/0022034513500306","volume":"92","author":"BF Boyce","year":"2013","unstructured":"Boyce, B. F. Advances in the regulation of osteoclasts and osteoclast functions. J. Dent. Res. 92, 860\u2013867 (2013).","journal-title":"J. Dent. Res."},{"key":"853_CR36","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.3390\/cells13131090","volume":"13","author":"M Ceylan","year":"2024","unstructured":"Ceylan, M. et al. Osteogenic differentiation of human gingival fibroblasts inhibits osteoclast formation. Cells 13, 1090 (2024).","journal-title":"Cells"},{"key":"853_CR37","doi-asserted-by":"publisher","first-page":"5826","DOI":"10.1016\/j.cell.2023.11.030","volume":"186","author":"JW Blayney","year":"2023","unstructured":"Blayney, J. W. et al. Super-enhancers include classical enhancers and facilitators to fully activate gene expression. Cell 186, 5826\u20135839.e18 (2023).","journal-title":"Cell"},{"key":"853_CR38","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.ymthe.2024.02.005","volume":"32","author":"X Huang","year":"2024","unstructured":"Huang, X. et al. M2 macrophages secrete glutamate-containing extracellular vesicles to alleviate osteoporosis by reshaping osteoclast precursor fate. Mol. Ther. 32, 1158\u20131177 (2024).","journal-title":"Mol. Ther."},{"key":"853_CR39","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s11914-022-00756-5","volume":"20","author":"AS Kim","year":"2022","unstructured":"Kim, A. S., Girgis, C. M. & McDonald, M. M. Osteoclast recycling and the rebound phenomenon following denosumab discontinuation. Curr. Osteoporos. Rep. 20, 505\u2013515 (2022).","journal-title":"Curr. Osteoporos. Rep."},{"key":"853_CR40","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.cell.2021.02.002","volume":"184","author":"MM McDonald","year":"2021","unstructured":"McDonald, M. M. et al. Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption. Cell 184, 1330\u20131347.e13 (2021).","journal-title":"Cell"},{"key":"853_CR41","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41586-019-1105-7","volume":"568","author":"CE Jacome-Galarza","year":"2019","unstructured":"Jacome-Galarza, C. E. et al. Developmental origin, functional maintenance and genetic rescue of osteoclasts. Nature 568, 541\u2013545 (2019).","journal-title":"Nature"},{"key":"853_CR42","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1242\/jcs.202036","volume":"130","author":"K S\u00f8e","year":"2017","unstructured":"S\u00f8e, K. & Delaiss\u00e9, J. M. Time-lapse reveals that osteoclasts can move across the bone surface while resorbing. J. Cell Sci. 130, 2026\u20132035 (2017).","journal-title":"J. Cell Sci."},{"key":"853_CR43","doi-asserted-by":"publisher","first-page":"868","DOI":"10.4049\/jimmunol.1900665","volume":"204","author":"S Novak","year":"2020","unstructured":"Novak, S. et al. Osteoclasts derive predominantly from bone marrow-resident CX(3)CR1(+) precursor cells in homeostasis, whereas circulating CX(3)CR1(+) cells contribute to osteoclast development during fracture repair. J. Immunol. 204, 868\u2013878 (2020).","journal-title":"J. Immunol."},{"key":"853_CR44","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1530\/EJE-16-1027","volume":"176","author":"AD Anastasilakis","year":"2017","unstructured":"Anastasilakis, A. D. et al. Increased osteoclastogenesis in patients with vertebral fractures following discontinuation of denosumab treatment. Eur. J. Endocrinol. 176, 677\u2013683 (2017).","journal-title":"Eur. J. Endocrinol."},{"key":"853_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05244-y","volume":"9","author":"J Xiong","year":"2018","unstructured":"Xiong, J. et al. Soluble RANKL contributes to osteoclast formation in adult mice but not ovariectomy-induced bone loss. Nat. Commun. 9, 2909 (2018).","journal-title":"Nat. Commun."},{"key":"853_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.896108","volume":"13","author":"J Chen","year":"2022","unstructured":"Chen, J. et al. Anti-osteoclast effect of exportin-1 inhibitor Eltanexor on osteoporosis depends on nuclear accumulation of I\u03baB\u03b1-NF-\u03baB p65 complex. Front. Pharm. 13, 896108 (2022).","journal-title":"Front. Pharm."},{"key":"853_CR47","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s12276-020-0484-z","volume":"52","author":"SH Mun","year":"2020","unstructured":"Mun, S. H., Park, P. S. U. & Park-Min, K. H. The M-CSF receptor in osteoclasts and beyond. Exp. Mol. Med. 52, 1239\u20131254 (2020).","journal-title":"Exp. Mol. Med."},{"key":"853_CR48","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.clinthera.2011.05.044","volume":"33","author":"JR Curtis","year":"2011","unstructured":"Curtis, J. R. & Singh, J. A. Use of biologics in rheumatoid arthritis: current and emerging paradigms of care. Clin. Ther. 33, 679\u2013707 (2011).","journal-title":"Clin. Ther."},{"key":"853_CR49","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.lfs.2016.02.004","volume":"148","author":"HM Doss","year":"2016","unstructured":"Doss, H. M., Dey, C., Sudandiradoss, C. & Rasool, M. K. Targeting inflammatory mediators with ferulic acid, a dietary polyphenol, for the suppression of monosodium urate crystal-induced inflammation in rats. Life Sci. 148, 201\u2013210 (2016).","journal-title":"Life Sci."},{"key":"853_CR50","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle, W. J., Simonet, W. S. & Lacey, D. L. Osteoclast differentiation and activation. Nature 423, 337\u2013342 (2003).","journal-title":"Nature"},{"key":"853_CR51","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1359\/jbmr.2003.18.3.443","volume":"18","author":"K Kanazawa","year":"2003","unstructured":"Kanazawa, K., Azuma, Y., Nakano, H. & Kudo, A. TRAF5 functions in both RANKL- and TNFalpha-induced osteoclastogenesis. J. Bone Min. Res. 18, 443\u2013450 (2003).","journal-title":"J. Bone Min. Res."},{"key":"853_CR52","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1359\/JBMR.041225","volume":"20","author":"K Kanazawa","year":"2005","unstructured":"Kanazawa, K. & Kudo, A. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis. J. Bone Min. Res. 20, 840\u2013847 (2005).","journal-title":"J. Bone Min. Res."},{"key":"853_CR53","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2535\/ofaj.94.101","volume":"94","author":"Y Honkura","year":"2017","unstructured":"Honkura, Y. et al. Nasolacrimal duct opening to the inferior nasal meatus in human fetuses. Okajimas Folia Anat. Jpn. 94, 101\u2013108 (2017).","journal-title":"Okajimas Folia Anat. Jpn."},{"key":"853_CR54","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1101\/gr.240093.118","volume":"29","author":"BA Benayoun","year":"2019","unstructured":"Benayoun, B. A. et al. Remodeling of epigenome and transcriptome landscapes with aging in mice reveals widespread induction of inflammatory responses. Genome Res. 29, 697\u2013709 (2019).","journal-title":"Genome Res."},{"key":"853_CR55","doi-asserted-by":"publisher","first-page":"35955","DOI":"10.1074\/jbc.274.50.35955","volume":"274","author":"H Levy","year":"1999","unstructured":"Levy, H., Kindle, K. L. & Stern, D. B. Target and specificity of a nuclear gene product that participates in mRNA 3\u2019-end formation in Chlamydomonas chloroplasts. J. Biol. Chem. 274, 35955\u201335962 (1999).","journal-title":"J. Biol. Chem."},{"key":"853_CR56","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1101\/gad.13.8.1015","volume":"13","author":"MA Lomaga","year":"1999","unstructured":"Lomaga, M. A. et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 13, 1015\u20131024 (1999).","journal-title":"Genes Dev."},{"key":"853_CR57","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1084\/jem.20050978","volume":"202","author":"N Kim","year":"2005","unstructured":"Kim, N. et al. Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J. Exp. Med. 202, 589\u2013595 (2005).","journal-title":"J. Exp. Med."},{"key":"853_CR58","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.7150\/ijbs.5079","volume":"8","author":"M Wu","year":"2012","unstructured":"Wu, M., Wang, Y., Deng, L., Chen, W. & Li, Y. P. TRAF family member-associated NF-\u03baB activator (TANK) induced by RANKL negatively regulates osteoclasts survival and function. Int. J. Biol. Sci. 8, 1398\u20131407 (2012).","journal-title":"Int. J. Biol. Sci."},{"key":"853_CR59","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","volume":"132","author":"MS Hayden","year":"2008","unstructured":"Hayden, M. S. & Ghosh, S. Shared principles in NF-kappaB signaling. Cell 132, 344\u2013362 (2008).","journal-title":"Cell"},{"key":"853_CR60","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2201490119","volume":"119","author":"V Deepak","year":"2022","unstructured":"Deepak, V. et al. IFT80 negatively regulates osteoclast differentiation via association with Cbl-b to disrupt TRAF6 stabilization and activation. Proc. Natl. Acad. Sci. USA 119, e2201490119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"853_CR61","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.tibs.2005.12.004","volume":"31","author":"PE Ryan","year":"2006","unstructured":"Ryan, P. E., Davies, G. C., Nau, M. M. & Lipkowitz, S. Regulating the regulator: negative regulation of Cbl ubiquitin ligases. Trends Biochem. Sci. 31, 79\u201388 (2006).","journal-title":"Trends Biochem. Sci."},{"key":"853_CR62","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s11658-019-0156-y","volume":"24","author":"HD Jang","year":"2019","unstructured":"Jang, H. D., Hwang, H. Z., Kim, H. S. & Lee, S. Y. C-Cbl negatively regulates TRAF6-mediated NF-\u03baB activation by promoting K48-linked polyubiquitination of TRAF6. Cell. Mol. Biol. Lett. 24, 29 (2019).","journal-title":"Cell. Mol. Biol. Lett."},{"key":"853_CR63","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1359\/jbmr.090205","volume":"24","author":"A Nakajima","year":"2009","unstructured":"Nakajima, A. et al. Loss of Cbl-b increases osteoclast bone-resorbing activity and induces osteopenia. J. Bone Min. Res. 24, 1162\u20131172 (2009).","journal-title":"J. Bone Min. Res."},{"key":"853_CR64","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.1091\/mbc.e09-03-0248","volume":"20","author":"E Purev","year":"2009","unstructured":"Purev, E., Neff, L., Horne, W. C. & Baron, R. c-Cbl and Cbl-b act redundantly to protect osteoclasts from apoptosis and to displace HDAC6 from beta-tubulin, stabilizing microtubules and podosomes. Mol. Biol. Cell 20, 4021\u20134030 (2009).","journal-title":"Mol. Biol. Cell"},{"key":"853_CR65","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1600-065X.2012.01097.x","volume":"246","author":"G Ghosh","year":"2012","unstructured":"Ghosh, G., Wang, V. Y., Huang, D. B. & Fusco, A. NF-\u03baB regulation: lessons from structures. Immunol. Rev. 246, 36\u201358 (2012).","journal-title":"Immunol. Rev."},{"key":"853_CR66","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1600-065X.2011.01088.x","volume":"246","author":"SC Sun","year":"2012","unstructured":"Sun, S. C. The noncanonical NF-\u03baB pathway. Immunol. Rev. 246, 125\u2013140 (2012).","journal-title":"Immunol. Rev."},{"key":"853_CR67","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrm2083","volume":"8","author":"ND Perkins","year":"2007","unstructured":"Perkins, N. D. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat. Rev. Mol. Cell Biol. 8, 49\u201362 (2007).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"853_CR68","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/embr.201337983","volume":"15","author":"M Hinz","year":"2014","unstructured":"Hinz, M. & Scheidereit, C. The I\u03baB kinase complex in NF-\u03baB regulation and beyond. EMBO Rep. 15, 46\u201361 (2014).","journal-title":"EMBO Rep."},{"key":"853_CR69","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1146\/annurev.immunol.021908.132641","volume":"27","author":"S Vallabhapurapu","year":"2009","unstructured":"Vallabhapurapu, S. & Karin, M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu. Rev. Immunol. 27, 693\u2013733 (2009).","journal-title":"Annu. Rev. Immunol."},{"key":"853_CR70","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.4049\/jimmunol.179.5.2681","volume":"179","author":"W Shibata","year":"2007","unstructured":"Shibata, W. et al. Cutting edge: The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks inflammatory injury in murine colitis. J. Immunol. 179, 2681\u20132685 (2007).","journal-title":"J. Immunol."},{"key":"853_CR71","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1084\/jem.20042081","volume":"201","author":"MG Ruocco","year":"2005","unstructured":"Ruocco, M. G. et al. I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss. J. Exp. Med. 201, 1677\u20131687 (2005).","journal-title":"J. Exp. Med."},{"key":"853_CR72","doi-asserted-by":"publisher","first-page":"7995","DOI":"10.3390\/ijms23147995","volume":"23","author":"E Jimi","year":"2022","unstructured":"Jimi, E. & Katagiri, T. Critical roles of NF-\u03baB signaling molecules in bone metabolism revealed by genetic mutations in osteopetrosis. Int. J. Mol. Sci. 23, 7995 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"853_CR73","doi-asserted-by":"publisher","first-page":"11085","DOI":"10.1073\/pnas.93.20.11085","volume":"93","author":"KM Kaye","year":"1996","unstructured":"Kaye, K. M. et al. Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein. Proc. Natl. Acad. Sci. USA 93, 11085\u201311090 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"853_CR74","doi-asserted-by":"publisher","first-page":"e31171","DOI":"10.1002\/jcp.31171","volume":"239","author":"JH Kim","year":"2024","unstructured":"Kim, J. H. et al. MCP-5 suppresses osteoclast differentiation through Ccr5 upregulation. J. Cell. Physiol. 239, e31171 (2024).","journal-title":"J. Cell. Physiol."},{"key":"853_CR75","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3390\/cells13020165","volume":"13","author":"P Louka","year":"2024","unstructured":"Louka, P., Orriss, I. R. & Pitsillides, A. A. Stable sulforaphane targets the early stages of osteoclast formation to engender a lasting functional blockade of osteoclastogenesis. Cells 13, 165 (2024).","journal-title":"Cells"},{"key":"853_CR76","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1002\/jcp.25378","volume":"231","author":"C Taylor-Kashton","year":"2016","unstructured":"Taylor-Kashton, C. et al. XPO1 inhibition preferentially disrupts the 3D nuclear organization of telomeres in tumor cells. J. Cell. Physiol. 231, 2711\u20132719 (2016).","journal-title":"J. Cell. Physiol."},{"key":"853_CR77","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12929-021-00753-3","volume":"28","author":"YD Lang","year":"2021","unstructured":"Lang, Y. D. & Jou, Y. S. PSPC1 is a new contextual determinant of aberrant subcellular translocation of oncogenes in tumor progression. J. Biomed. Sci. 28, 57 (2021).","journal-title":"J. Biomed. Sci."},{"key":"853_CR78","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.1158\/1078-0432.CCR-16-2632","volume":"23","author":"JS Nair","year":"2017","unstructured":"Nair, J. S., Musi, E. & Schwartz, G. K. Selinexor (KPT-330) induces tumor suppression through nuclear sequestration of I\u03baB and downregulation of survivin. Clin. Cancer Res. 23, 4301\u20134311 (2017).","journal-title":"Clin. Cancer Res."},{"key":"853_CR79","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/ijms26010010","volume":"26","author":"X Fan","year":"2024","unstructured":"Fan, X. et al. Hypoxia promotes osteoclast differentiation by weakening USP18-mediated suppression on the NF-\u03baB signaling pathway. Int. J. Mol. Sci. 26, 10 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"853_CR80","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1093\/bbb\/zbae164","volume":"89","author":"L McCallum","year":"2025","unstructured":"McCallum, L. & Fox, S. W. d-limonene suppresses RANKL-induced osteoclast differentiation and promotes osteoblast activity in vitro. Biosci. Biotechnol. Biochem. 89, 232\u2013240 (2025).","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"853_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114073","volume":"148","author":"C Xiang","year":"2025","unstructured":"Xiang, C. et al. Oleandrin inhibits osteoclast differentiation by targeting the LRP4\/MAPK\/NF-\u03baB signalling pathway to treat osteoporosis. Int. Immunopharmacol. 148, 114073 (2025).","journal-title":"Int. Immunopharmacol."},{"key":"853_CR82","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3390\/cells11010132","volume":"11","author":"Z Yao","year":"2021","unstructured":"Yao, Z., Getting, S. J. & Locke, I. C. Regulation of TNF-induced osteoclast differentiation. Cells 11, 132 (2021).","journal-title":"Cells"},{"key":"853_CR83","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.it.2004.03.008","volume":"25","author":"G Bonizzi","year":"2004","unstructured":"Bonizzi, G. & Karin, M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25, 280\u2013288 (2004).","journal-title":"Trends Immunol."},{"key":"853_CR84","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1126\/science.1062677","volume":"293","author":"U Senftleben","year":"2001","unstructured":"Senftleben, U. et al. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 293, 1495\u20131499 (2001).","journal-title":"Science"},{"key":"853_CR85","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/978-981-13-9367-9_10","volume":"1172","author":"MC Mulero","year":"2019","unstructured":"Mulero, M. C., Huxford, T. & Ghosh, G. NF-\u03baB, I\u03baB, and IKK: Integral components of immune system signaling. Adv. Exp. Med. Biol. 1172, 207\u2013226 (2019).","journal-title":"Adv. Exp. Med. Biol."},{"key":"853_CR86","doi-asserted-by":"publisher","first-page":"3688","DOI":"10.1074\/jbc.M610271200","volume":"282","author":"JQ He","year":"2007","unstructured":"He, J. Q., Saha, S. K., Kang, J. R., Zarnegar, B. & Cheng, G. Specificity of TRAF3 in its negative regulation of the noncanonical NF-kappa B pathway. J. Biol. Chem. 282, 3688\u20133694 (2007).","journal-title":"J. Biol. Chem."},{"key":"853_CR87","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1084\/jem.20061166","volume":"203","author":"JQ He","year":"2006","unstructured":"He, J. Q. et al. Rescue of TRAF3-null mice by p100 NF-kappa B deficiency. J. Exp. Med. 203, 2413\u20132418 (2006).","journal-title":"J. Exp. Med."},{"key":"853_CR88","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1172\/JCI66947","volume":"124","author":"Y Xiu","year":"2014","unstructured":"Xiu, Y. et al. Chloroquine reduces osteoclastogenesis in murine osteoporosis by preventing TRAF3 degradation. J. Clin. Invest. 124, 297\u2013310 (2014).","journal-title":"J. Clin. Invest."},{"key":"853_CR89","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1182\/blood-2004-07-2534","volume":"105","author":"HB Kwak","year":"2005","unstructured":"Kwak, H. B. et al. Monokine induced by interferon-gamma is induced by receptor activator of nuclear factor kappa B ligand and is involved in osteoclast adhesion and migration. Blood 105, 2963\u20132969 (2005).","journal-title":"Blood"},{"key":"853_CR90","doi-asserted-by":"publisher","first-page":"4317","DOI":"10.1242\/jcs.00082","volume":"115","author":"JP David","year":"2002","unstructured":"David, J. P., Sabapathy, K., Hoffmann, O., Idarraga, M. H. & Wagner, E. F. JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms. J. Cell Sci. 115, 4317\u20134325 (2002).","journal-title":"J. Cell Sci."},{"key":"853_CR91","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1359\/jbmr.2002.17.4.612","volume":"17","author":"A Yamamoto","year":"2002","unstructured":"Yamamoto, A. et al. Possible involvement of IkappaB kinase 2 and MKK7 in osteoclastogenesis induced by receptor activator of nuclear factor kappaB ligand. J. Bone Min. Res. 17, 612\u2013621 (2002).","journal-title":"J. Bone Min. Res."},{"key":"853_CR92","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.7150\/ijbs.70620","volume":"18","author":"CY Tang","year":"2022","unstructured":"Tang, C. Y. et al. GPR125 positively regulates osteoclastogenesis potentially through AKT-NF-\u03baB and MAPK signaling pathways. Int. J. Biol. Sci. 18, 2392\u20132405 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"853_CR93","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.7150\/ijbs.41867","volume":"16","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y., Wang, H., Zhu, G., Qian, A. & Chen, W. F2r negatively regulates osteoclastogenesis through inhibiting the Akt and NF\u03baB signaling pathways. Int. J. Biol. Sci. 16, 1629\u20131639 (2020).","journal-title":"Int. J. Biol. Sci."},{"key":"853_CR94","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00109-025-02523-2","volume":"103","author":"BC Kim","year":"2025","unstructured":"Kim, B. C. et al. Role of endosomal RANKL-LGR4 signaling during osteoclast differentiation. J. Mol. Med. 103, 339\u2013354 (2025).","journal-title":"J. Mol. Med."},{"key":"853_CR95","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3390\/cancers16020302","volume":"16","author":"Z Lei","year":"2024","unstructured":"Lei, Z. et al. The miR-19a\/cylindromatosis axis regulates pituitary adenoma bone invasion by promoting osteoclast differentiation. Cancers 16, 302 (2024).","journal-title":"Cancers"},{"key":"853_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-57898-y","volume":"14","author":"M Materozzi","year":"2024","unstructured":"Materozzi, M. et al. A novel proteomic signature of osteoclast differentiation unveils the deubiquitinase UCHL1 as a necessary osteoclastogenic driver. Sci. Rep. 14, 7290 (2024).","journal-title":"Sci. Rep."},{"key":"853_CR97","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/j.cmet.2024.03.005","volume":"36","author":"Y Dong","year":"2024","unstructured":"Dong, Y. et al. A clinical-stage Nrf2 activator suppresses osteoclast differentiation via the iron-ornithine axis. Cell Metab. 36, 1679\u20131695.e6 (2024).","journal-title":"Cell Metab."},{"key":"853_CR98","doi-asserted-by":"crossref","unstructured":"Liu, Y. C. G. & Teng, A. Y. Distinct cross talk of IL-17 & TGF-\u03b2 with the immature CD11c+ TRAF6(-\/-)-null myeloid dendritic cell-derived osteoclast precursor (mDDOCp) may engage signaling toward an alternative pathway of osteoclastogenesis for arthritic bone loss in vivo. Immun. Inflamm. Dis. 12, e1173 (2024).","DOI":"10.1002\/iid3.1173"},{"key":"853_CR99","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/jdb9030024","volume":"9","author":"B Heubel","year":"2021","unstructured":"Heubel, B. & Nohe, A. The role of BMP signaling in osteoclast regulation. J. Dev. Biol. 9, 24 (2021).","journal-title":"J. Dev. Biol."},{"key":"853_CR100","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1002\/jbmr.3146","volume":"32","author":"A Li","year":"2017","unstructured":"Li, A. et al. Pharmacologic calcitriol inhibits osteoclast lineage commitment via the BMP-Smad1 and I\u03baB-NF-\u03baB pathways. J. Bone Min. Res. 32, 1406\u20131420 (2017).","journal-title":"J. Bone Min. Res."},{"key":"853_CR101","doi-asserted-by":"crossref","unstructured":"Lin, A. et al. D-Ala(2))GIP inhibits inflammatory bone resorption by suppressing TNF-\u03b1 and RANKL expression and directly impeding osteoclast formation. Int. J. Mol. Sci. 25, 2555 (2024).","DOI":"10.3390\/ijms25052555"},{"key":"853_CR102","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1182\/blood-2012-07-446443","volume":"121","author":"S Khurana","year":"2013","unstructured":"Khurana, S. et al. A novel role of BMP4 in adult hematopoietic stem and progenitor cell homing via Smad independent regulation of integrin-\u03b14 expression. Blood 121, 781\u2013790 (2013).","journal-title":"Blood"},{"key":"853_CR103","doi-asserted-by":"crossref","unstructured":"Sun, S. X. et al. BMP-2 and titanium particles synergistically activate osteoclast formation. Braz. J. Med. Biol. Res. 47, 461\u2013469 (2014).","DOI":"10.1590\/1414-431X20132966"},{"key":"853_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2024.117303","volume":"190","author":"N Kodama","year":"2025","unstructured":"Kodama, N. et al. BMP3b regulates bone mass by inhibiting BMP signaling. Bone 190, 117303 (2025).","journal-title":"Bone"},{"key":"853_CR105","doi-asserted-by":"publisher","first-page":"115474","DOI":"10.1016\/j.bone.2020.115474","volume":"138","author":"J Yu","year":"2020","unstructured":"Yu, J. & Canalis, E. Notch and the regulation of osteoclast differentiation and function. Bone 138, 115474 (2020).","journal-title":"Bone"},{"key":"853_CR106","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/ejo\/cjs002","volume":"35","author":"L Duan","year":"2013","unstructured":"Duan, L. & Ren, Y. Role of notch signaling in osteoimmunology\u2013from the standpoint of osteoclast differentiation. Eur. J. Orthod. 35, 175\u2013182 (2013).","journal-title":"Eur. J. Orthod."},{"key":"853_CR107","doi-asserted-by":"publisher","first-page":"105613","DOI":"10.1016\/j.jbc.2023.105613","volume":"300","author":"E Canalis","year":"2024","unstructured":"Canalis, E., Schilling, L., Yu, J. & Denker, E. NOTCH2 promotes osteoclast maturation and metabolism and modulates the transcriptome profile during osteoclastogenesis. J. Biol. Chem. 300, 105613 (2024).","journal-title":"J. Biol. Chem."},{"key":"853_CR108","doi-asserted-by":"publisher","first-page":"7064","DOI":"10.2741\/3210","volume":"13","author":"L Duan","year":"2008","unstructured":"Duan, L., de Vos, P., Fan, M. & Ren, Y. Notch is activated in RANKL-induced osteoclast differentiation and resorption. Front. Biosci. 13, 7064\u20137071 (2008).","journal-title":"Front. Biosci."},{"key":"853_CR109","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1749-6632.2009.05307.x","volume":"1192","author":"J Tao","year":"2010","unstructured":"Tao, J., Chen, S. & Lee, B. Alteration of Notch signaling in skeletal development and disease. Ann. N. Y. Acad. Sci. 1192, 257\u2013268 (2010).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"853_CR110","doi-asserted-by":"publisher","first-page":"6509","DOI":"10.1074\/jbc.M707000200","volume":"283","author":"S Bai","year":"2008","unstructured":"Bai, S. et al. NOTCH1 regulates osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblast lineage cells. J. Biol. Chem. 283, 6509\u20136518 (2008).","journal-title":"J. Biol. Chem."},{"key":"853_CR111","doi-asserted-by":"crossref","unstructured":"Jin, W. J. et al. Notch2 signaling promotes osteoclast resorption via activation of PYK2. Cell Signal. 28, 357\u2013365 (2016).","DOI":"10.1016\/j.cellsig.2016.01.016"},{"key":"853_CR112","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1002\/jcp.26372","volume":"233","author":"W Yang","year":"2018","unstructured":"Yang, W. et al. The emerging role of Hippo signaling pathway in regulating osteoclast formation. J. Cell Physiol. 233, 4606\u20134617 (2018).","journal-title":"J. Cell Physiol."},{"key":"853_CR113","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2741\/4232","volume":"19","author":"D Keinan","year":"2014","unstructured":"Keinan, D. et al. Role of regulator of G protein signaling proteins in bone. Front. Biosci. 19, 634\u2013648 (2014).","journal-title":"Front. Biosci."},{"key":"853_CR114","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/bs.pmbts.2015.02.002","volume":"133","author":"J Jules","year":"2015","unstructured":"Jules, J., Yang, S., Chen, W. & Li, Y. P. Role of regulators of G protein signaling proteins in bone physiology and pathophysiology. Prog. Mol. Biol. Transl. Sci. 133, 47\u201375 (2015).","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"853_CR115","doi-asserted-by":"publisher","first-page":"957","DOI":"10.2741\/3656","volume":"15","author":"M Wu","year":"2010","unstructured":"Wu, M., Deng, L., Zhu, G. & Li, Y. P. G Protein and its signaling pathway in bone development and disease. Front. Biosci. 15, 957\u2013985 (2010).","journal-title":"Front. Biosci."},{"key":"853_CR116","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S1097-2765(01)00211-8","volume":"7","author":"X Luo","year":"2001","unstructured":"Luo, X., Popov, S., Bera, A. K., Wilkie, T. M. & Muallem, S. RGS proteins provide biochemical control of agonist-evoked [Ca2+]i oscillations. Mol. Cell 7, 651\u2013660 (2001).","journal-title":"Mol. Cell"},{"key":"853_CR117","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1101\/gad.1544107","volume":"21","author":"S Yang","year":"2007","unstructured":"Yang, S. & Li, Y. P. RGS10-null mutation impairs osteoclast differentiation resulting from the loss of [Ca2+]i oscillation regulation. Genes Dev. 21, 1803\u20131816 (2007).","journal-title":"Genes Dev."},{"key":"853_CR118","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/35047093","volume":"408","author":"ML Schiff","year":"2000","unstructured":"Schiff, M. L. et al. Tyrosine-kinase-dependent recruitment of RGS12 to the N-type calcium channel. Nature 408, 723\u2013727 (2000).","journal-title":"Nature"},{"key":"853_CR119","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1359\/jbmr.061007","volume":"22","author":"S Yang","year":"2007","unstructured":"Yang, S. & Li, Y. P. RGS12 is essential for RANKL-evoked signaling for terminal differentiation of osteoclasts in vitro. J. Bone Min. Res. 22, 45\u201354 (2007).","journal-title":"J. Bone Min. Res."},{"key":"853_CR120","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/dvg.22373","volume":"51","author":"S Yang","year":"2013","unstructured":"Yang, S. et al. Mx1-cre mediated Rgs12 conditional knockout mice exhibit increased bone mass phenotype. Genesis 51, 201\u2013209 (2013).","journal-title":"Genesis"},{"key":"853_CR121","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1172\/JCI30074","volume":"117","author":"Y Gao","year":"2007","unstructured":"Gao, Y. et al. IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J. Clin. Invest. 117, 122\u2013132 (2007).","journal-title":"J. Clin. Invest."},{"key":"853_CR122","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0092-8674(93)80061-I","volume":"75","author":"JW Putney Jr.","year":"1993","unstructured":"Putney, J. W. Jr. & Bird, G. S. The signal for capacitative calcium entry. Cell 75, 199\u2013201 (1993).","journal-title":"Cell"},{"key":"853_CR123","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/364809a0","volume":"364","author":"C Randriamampita","year":"1993","unstructured":"Randriamampita, C. & Tsien, R. Y. Emptying of intracellular Ca2+ stores releases a novel small messenger that stimulates Ca2+ influx. Nature 364, 809\u2013814 (1993).","journal-title":"Nature"},{"key":"853_CR124","doi-asserted-by":"publisher","first-page":"3362","DOI":"10.1242\/jcs.008300","volume":"120","author":"S Yang","year":"2007","unstructured":"Yang, S., Chen, W., Stashenko, P. & Li, Y. P. Specificity of RGS10A as a key component in the RANKL signaling mechanism for osteoclast differentiation. J. Cell Sci. 120, 3362\u20133371 (2007).","journal-title":"J. Cell Sci."},{"key":"853_CR125","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/hmg\/ddl474","volume":"16","author":"W Chen","year":"2007","unstructured":"Chen, W. et al. Novel pycnodysostosis mouse model uncovers cathepsin K function as a potential regulator of osteoclast apoptosis and senescence. Hum. Mol. Genet. 16, 410\u2013423 (2007).","journal-title":"Hum. Mol. Genet."},{"key":"853_CR126","doi-asserted-by":"publisher","first-page":"5508","DOI":"10.3390\/ijms23105508","volume":"23","author":"T Matsubara","year":"2022","unstructured":"Matsubara, T., Yasuda, K., Mizuta, K., Kawaue, H. & Kokabu, S. Tyrosine kinase Src is a regulatory factor of bone homeostasis. Int. J. Mol. Sci. 23, 5508 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"853_CR127","doi-asserted-by":"crossref","unstructured":"Izawa, T. et al. c-Src links a RANK\/\u03b1v\u03b23 integrin complex to the osteoclast cytoskeleton. Mol. Cell. Biol. 32, 2943\u20132953 (2012).","DOI":"10.1128\/MCB.00077-12"},{"key":"853_CR128","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1083\/jcb.152.1.181","volume":"152","author":"A Sanjay","year":"2001","unstructured":"Sanjay, A. et al. Cbl associates with Pyk2 and Src to regulate Src kinase activity, alpha(v)beta(3) integrin-mediated signaling, cell adhesion, and osteoclast motility. J. Cell Biol. 152, 181\u2013195 (2001).","journal-title":"J. Cell Biol."},{"key":"853_CR129","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.bbrc.2017.05.174","volume":"489","author":"T Matsubara","year":"2017","unstructured":"Matsubara, T. et al. Regulation of osteoclast differentiation and actin ring formation by the cytolinker protein plectin. Biochem. Biophys. Res. Commun. 489, 472\u2013476 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"853_CR130","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.stem.2010.11.027","volume":"8","author":"X Li","year":"2011","unstructured":"Li, X. et al. Calcineurin-NFAT signaling critically regulates early lineage specification in mouse embryonic stem cells and embryos. Cell Stem Cell 8, 46\u201358 (2011).","journal-title":"Cell Stem Cell"},{"key":"853_CR131","doi-asserted-by":"publisher","first-page":"3646","DOI":"10.3390\/ijms21103646","volume":"21","author":"JY Kang","year":"2020","unstructured":"Kang, J. Y., Kang, N., Yang, Y. M., Hong, J. H. & Shin, D. M. The role of Ca(2+)-NFATc1 signaling and its modulation on osteoclastogenesis. Int. J. Mol. Sci. 21, 3646 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"853_CR132","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1073\/pnas.90.10.4485","volume":"90","author":"C Lowe","year":"1993","unstructured":"Lowe, C. et al. Osteopetrosis in Src-deficient mice is due to an autonomous defect of osteoclasts. Proc. Natl. Acad. Sci. USA 90, 4485\u20134489 (1993).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"853_CR133","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-40974-z","volume":"9","author":"S Nakano","year":"2019","unstructured":"Nakano, S. et al. G-protein G\u03b1(13) functions as a cytoskeletal and mitochondrial regulator to restrain osteoclast function. Sci. Rep. 9, 4236 (2019).","journal-title":"Sci. Rep."},{"key":"853_CR134","first-page":"55","volume":"33","author":"Z Qiu","year":"2022","unstructured":"Qiu, Z. et al. Puerarin specifically disrupts osteoclast activation via blocking integrin-\u03b23 Pyk2\/Src\/Cbl signaling pathway. J. Orthop. Transl. 33, 55\u201369 (2022).","journal-title":"J. Orthop. Transl."},{"key":"853_CR135","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/0092-8674(91)90499-O","volume":"64","author":"P Soriano","year":"1991","unstructured":"Soriano, P., Montgomery, C., Geske, R. & Bradley, A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64, 693\u2013702 (1991).","journal-title":"Cell"},{"key":"853_CR136","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.bone.2015.11.010","volume":"83","author":"LZ Zheng","year":"2016","unstructured":"Zheng, L. Z. et al. Src siRNA prevents corticosteroid-associated osteoporosis in a rabbit model. Bone 83, 190\u2013196 (2016).","journal-title":"Bone"},{"key":"853_CR137","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s12010-023-04515-9","volume":"196","author":"K Bin Karim","year":"2024","unstructured":"Bin Karim, K., Giribabu, N. & Bin Salleh, N. Marantodes pumilum (Kacip Fatimah) aqueous extract enhances osteoblast and suppresses osteoclast activities in cancellous bone of a rat model of postmenopause. Appl. Biochem. Biotechnol. 196, 821\u2013840 (2024).","journal-title":"Appl. Biochem. Biotechnol."},{"key":"853_CR138","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1038\/nm.2007","volume":"15","author":"B Zhao","year":"2009","unstructured":"Zhao, B. et al. Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis. Nat. Med. 15, 1066\u20131071 (2009).","journal-title":"Nat. Med."},{"key":"853_CR139","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1002\/jbmr.3689","volume":"34","author":"N Izawa","year":"2019","unstructured":"Izawa, N. et al. Cooperation of PU.1 with IRF8 and NFATc1 defines chromatin landscapes during RANKL-induced osteoclastogenesis. J. Bone Min. Res. 34, 1143\u20131154 (2019).","journal-title":"J. Bone Min. Res."},{"key":"853_CR140","doi-asserted-by":"publisher","first-page":"9511","DOI":"10.1073\/pnas.1901258116","volume":"116","author":"H Wang","year":"2019","unstructured":"Wang, H. et al. Transcription factors IRF8 and PU.1 are required for follicular B cell development and BCL6-driven germinal center responses. Proc. Natl. Acad. Sci. USA 116, 9511\u20139520 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"853_CR141","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1073\/pnas.0912779107","volume":"107","author":"K Nishikawa","year":"2010","unstructured":"Nishikawa, K. et al. Blimp1-mediated repression of negative regulators is required for osteoclast differentiation. Proc. Natl. Acad. Sci. USA 107, 3117\u20133122 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"853_CR142","doi-asserted-by":"publisher","first-page":"22918","DOI":"10.18632\/oncotarget.4382","volume":"6","author":"L Zhang","year":"2015","unstructured":"Zhang, L. et al. The E3 ubiquitin ligase Cbl-b improves the prognosis of RANK positive breast cancer patients by inhibiting RANKL-induced cell migration and metastasis. Oncotarget 6, 22918\u201322933 (2015).","journal-title":"Oncotarget"},{"key":"853_CR143","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","volume":"3","author":"H Takayanagi","year":"2002","unstructured":"Takayanagi, H. et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3, 889\u2013901 (2002).","journal-title":"Dev. Cell"},{"key":"853_CR144","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.cell.2007.07.025","volume":"130","author":"T Nakamura","year":"2007","unstructured":"Nakamura, T. et al. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 130, 811\u2013823 (2007).","journal-title":"Cell"},{"key":"853_CR145","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s00402-014-2070-0","volume":"134","author":"SK Chow","year":"2014","unstructured":"Chow, S. K., Leung, K. S., Qin, L., Wei, F. & Cheung, W. H. Callus formation is related to the expression ratios of estrogen receptors-alpha and -beta in ovariectomy-induced osteoporotic fracture healing. Arch. Orthop. Trauma Surg. 134, 1405\u20131416 (2014).","journal-title":"Arch. Orthop. Trauma Surg."},{"key":"853_CR146","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0092-8674(00)80257-3","volume":"89","author":"P Ducy","year":"1997","unstructured":"Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L. & Karsenty, G. Osf2\/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89, 747\u2013754 (1997).","journal-title":"Cell"},{"key":"853_CR147","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0092-8674(90)90219-5","volume":"61","author":"MJ Klemsz","year":"1990","unstructured":"Klemsz, M. J., McKercher, S. R., Celada, A., Van Beveren, C. & Maki, R. A. The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell 61, 113\u2013124 (1990).","journal-title":"Cell"},{"key":"853_CR148","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1126\/science.3296191","volume":"236","author":"T Maniatis","year":"1987","unstructured":"Maniatis, T., Goodbourn, S. & Fischer, J. A. Regulation of inducible and tissue-specific gene expression. Science 236, 1237\u20131245 (1987).","journal-title":"Science"},{"key":"853_CR149","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.1074\/jbc.270.10.4955","volume":"270","author":"SH Orkin","year":"1995","unstructured":"Orkin, S. H. Transcription factors and hematopoietic development. J. Biol. Chem. 270, 4955\u20134958 (1995).","journal-title":"J. Biol. Chem."},{"key":"853_CR150","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0092-8674(00)80240-8","volume":"89","author":"W Zheng","year":"1997","unstructured":"Zheng, W. & Flavell, R. A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89, 587\u2013596 (1997).","journal-title":"Cell"},{"key":"853_CR151","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/0092-8674(92)90592-Z","volume":"71","author":"RS Johnson","year":"1992","unstructured":"Johnson, R. S., Spiegelman, B. M. & Papaioannou, V. Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell 71, 577\u2013586 (1992).","journal-title":"Cell"},{"key":"853_CR152","first-page":"6244","volume":"55","author":"ZQ Wang","year":"1995","unstructured":"Wang, Z. Q., Liang, J., Schellander, K., Wagner, E. F. & Grigoriadis, A. E. c-fos-induced osteosarcoma formation in transgenic mice: cooperativity with c-jun and the role of endogenous c-fos. Cancer Res. 55, 6244\u20136251 (1995).","journal-title":"Cancer Res."},{"key":"853_CR153","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.bone.2003.08.014","volume":"34","author":"CL Hershey","year":"2004","unstructured":"Hershey, C. L. & Fisher, D. E. Mitf and Tfe3: members of a b-HLH-ZIP transcription factor family essential for osteoclast development and function. Bone 34, 689\u2013696 (2004).","journal-title":"Bone"},{"key":"853_CR154","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1101\/sqb.1999.64.13","volume":"64","author":"H Singh","year":"1999","unstructured":"Singh, H., DeKoter, R. P. & Walsh, J. C. PU.1, a shared transcriptional regulator of lymphoid and myeloid cell fates. Cold Spring Harb. Symp. Quant. Biol. 64, 13\u201320 (1999).","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"853_CR155","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/386081a0","volume":"386","author":"MM Tondravi","year":"1997","unstructured":"Tondravi, M. M. et al. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature 386, 81\u201384 (1997).","journal-title":"Nature"},{"key":"853_CR156","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.bbrc.2005.07.092","volume":"335","author":"OH Kwon","year":"2005","unstructured":"Kwon, O. H., Lee, C. K., Lee, Y. I., Paik, S. G. & Lee, H. J. The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors. Biochem. Biophys. Res. Commun. 335, 437\u2013446 (2005).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"853_CR157","doi-asserted-by":"publisher","first-page":"45969","DOI":"10.1074\/jbc.M408795200","volume":"279","author":"M Matsumoto","year":"2004","unstructured":"Matsumoto, M. et al. Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1. J. Biol. Chem. 279, 45969\u201345979 (2004).","journal-title":"J. Biol. Chem."},{"key":"853_CR158","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.bone.2003.11.010","volume":"34","author":"GA Partington","year":"2004","unstructured":"Partington, G. A., Fuller, K., Chambers, T. J. & Pondel, M. Mitf-PU.1 interactions with the tartrate-resistant acid phosphatase gene promoter during osteoclast differentiation. Bone 34, 237\u2013245 (2004).","journal-title":"Bone"},{"key":"853_CR159","doi-asserted-by":"crossref","unstructured":"Hu, R. et al. Eos, MITF, and PU.1 recruit corepressors to osteoclast-specific genes in committed myeloid progenitors. Mol. Cell. Biol. 27, 4018\u20134027 (2007).","DOI":"10.1128\/MCB.01839-06"},{"key":"853_CR160","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ceb.2022.01.001","volume":"74","author":"H Okada","year":"2022","unstructured":"Okada, H. & Tanaka, S. Plasmalemmal interface for calcium signaling in osteoclast differentiation. Curr. Opin. Cell Biol. 74, 55\u201361 (2022).","journal-title":"Curr. Opin. Cell Biol."},{"key":"853_CR161","doi-asserted-by":"publisher","first-page":"26475","DOI":"10.1074\/jbc.M313973200","volume":"279","author":"K Matsuo","year":"2004","unstructured":"Matsuo, K. et al. Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. J. Biol. Chem. 279, 26475\u201326480 (2004).","journal-title":"J. Biol. Chem."},{"key":"853_CR162","doi-asserted-by":"crossref","unstructured":"Day, C. J., Kim, M. S., Lopez, C. M., Nicholson, G. C. & Morrison, N. A. NFAT expression in human osteoclasts. J. Cell. Biochem. 95, 17\u201323 (2005).","DOI":"10.1002\/jcb.20410"},{"key":"853_CR163","doi-asserted-by":"publisher","first-page":"29496","DOI":"10.3390\/ijms161226179","volume":"16","author":"GH Quan","year":"2015","unstructured":"Quan, G. H. et al. Calycosin suppresses RANKL-mediated osteoclastogenesis through inhibition of MAPKs and NF-\u03baB. Int. J. Mol. Sci. 16, 29496\u201329507 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"853_CR164","doi-asserted-by":"publisher","DOI":"10.1038\/srep13575","volume":"5","author":"Y Zhang","year":"2015","unstructured":"Zhang, Y. et al. Amlexanox suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss. Sci. Rep. 5, 13575 (2015).","journal-title":"Sci. Rep."},{"key":"853_CR165","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s00109-004-0612-6","volume":"83","author":"H Takayanagi","year":"2005","unstructured":"Takayanagi, H. Mechanistic insight into osteoclast differentiation in osteoimmunology. J. Mol. Med. 83, 170\u2013179 (2005).","journal-title":"J. Mol. Med."},{"key":"853_CR166","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1084\/jem.184.1.101","volume":"184","author":"N Ho","year":"1996","unstructured":"Ho, N., Gullberg, M. & Chatila, T. Activation protein 1-dependent transcriptional activation of interleukin 2 gene by Ca2+\/calmodulin kinase type IV\/Gr. J. Exp. Med. 184, 101\u2013112 (1996).","journal-title":"J. Exp. Med."},{"key":"853_CR167","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.isci.2018.12.018","volume":"11","author":"HA Carey","year":"2019","unstructured":"Carey, H. A. et al. Eomes partners with PU.1 and MITF to regulate transcription factors critical for osteoclast differentiation. iScience 11, 238\u2013245 (2019).","journal-title":"iScience"},{"key":"853_CR168","doi-asserted-by":"publisher","first-page":"24209","DOI":"10.1074\/jbc.M302940200","volume":"278","author":"H So","year":"2003","unstructured":"So, H. et al. Microphthalmia transcription factor and PU.1 synergistically induce the leukocyte receptor osteoclast-associated receptor gene expression. J. Biol. Chem. 278, 24209\u201324216 (2003).","journal-title":"J. Biol. Chem."},{"key":"853_CR169","doi-asserted-by":"publisher","first-page":"11077","DOI":"10.1074\/jbc.M111696200","volume":"277","author":"KC Mansky","year":"2002","unstructured":"Mansky, K. C., Sankar, U., Han, J. & Ostrowski, M. C. Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-kappa B ligand signaling. J. Biol. Chem. 277, 11077\u201311083 (2002).","journal-title":"J. Biol. Chem."},{"key":"853_CR170","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S1097-2765(01)00360-4","volume":"8","author":"KN Weilbaecher","year":"2001","unstructured":"Weilbaecher, K. N. et al. Linkage of M-CSF signaling to Mitf, TFE3, and the osteoclast defect in Mitf(mi\/mi) mice. Mol. Cell 8, 749\u2013758 (2001).","journal-title":"Mol. Cell"},{"key":"853_CR171","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1016\/j.devcel.2025.02.001","volume":"60","author":"N Haacke","year":"2025","unstructured":"Haacke, N. et al. Innate immune training of osteoclastogenesis promotes inflammatory bone loss in mice. Dev. Cell 60, 1854\u20131870.e6 (2025).","journal-title":"Dev. Cell"},{"key":"853_CR172","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1101\/gad.2.7.786","volume":"2","author":"WH Landschulz","year":"1988","unstructured":"Landschulz, W. H., Johnson, P. F., Adashi, E. Y., Graves, B. J. & McKnight, S. L. Isolation of a recombinant copy of the gene encoding C\/EBP. Genes Dev. 2, 786\u2013800 (1988).","journal-title":"Genes Dev."},{"key":"853_CR173","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.tcb.2007.07.004","volume":"17","author":"C Nerlov","year":"2007","unstructured":"Nerlov, C. The C\/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control. Trends Cell Biol. 17, 318\u2013324 (2007).","journal-title":"Trends Cell Biol."},{"key":"853_CR174","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1042\/bj20020508","volume":"365","author":"DP Ramji","year":"2002","unstructured":"Ramji, D. P. & Foka, P. CCAAT\/enhancer-binding proteins: structure, function and regulation. Biochem. J. 365, 561\u2013575 (2002).","journal-title":"Biochem. J."},{"key":"853_CR175","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.immuni.2004.11.006","volume":"21","author":"P Zhang","year":"2004","unstructured":"Zhang, P. et al. Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C\/EBP alpha. Immunity 21, 853\u2013863 (2004).","journal-title":"Immunity"},{"key":"853_CR176","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/01.moh.0000190110.08156.96","volume":"13","author":"BU Mueller","year":"2006","unstructured":"Mueller, B. U. & Pabst, T. C\/EBPalpha and the pathophysiology of acute myeloid leukemia. Curr. Opin. Hematol. 13, 7\u201314 (2006).","journal-title":"Curr. Opin. Hematol."},{"key":"853_CR177","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1073\/pnas.94.2.569","volume":"94","author":"DE Zhang","year":"1997","unstructured":"Zhang, D. E. et al. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. Proc. Natl. Acad. Sci. USA 94, 569\u2013574 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"853_CR178","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1126\/science.7652557","volume":"269","author":"ND Wang","year":"1995","unstructured":"Wang, N. D. et al. Impaired energy homeostasis in C\/EBP alpha knockout mice. Science 269, 1108\u20131112 (1995).","journal-title":"Science"},{"key":"853_CR179","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/ncb2698","volume":"15","author":"M Ye","year":"2013","unstructured":"Ye, M. et al. C\/EBPa controls acquisition and maintenance of adult haematopoietic stem cell quiescence. Nat. Cell Biol. 15, 385\u2013394 (2013).","journal-title":"Nat. Cell Biol."},{"key":"853_CR180","doi-asserted-by":"publisher","first-page":"16390","DOI":"10.1074\/jbc.M115.674598","volume":"291","author":"J Jules","year":"2016","unstructured":"Jules, J., Chen, W., Feng, X. & Li, Y. P. CCAAT\/enhancer-binding protein \u03b1 (C\/EBP\u03b1) is important for osteoclast differentiation and activity. J. Biol. Chem. 291, 16390\u201316403 (2016).","journal-title":"J. Biol. Chem."},{"key":"853_CR181","doi-asserted-by":"publisher","first-page":"9606","DOI":"10.1073\/pnas.90.20.9606","volume":"90","author":"FT Lin","year":"1993","unstructured":"Lin, F. T., MacDougald, O. A., Diehl, A. M. & Lane, M. D. A 30-kDa alternative translation product of the CCAAT\/enhancer binding protein alpha message: transcriptional activator lacking antimitotic activity. Proc. Natl. Acad. Sci. USA 90, 9606\u20139610 (1993).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"853_CR182","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s12185-010-0573-1","volume":"91","author":"K Reckzeh","year":"2010","unstructured":"Reckzeh, K. & Cammenga, J. Molecular mechanisms underlying deregulation of C\/EBPalpha in acute myeloid leukemia. Int. J. Hematol. 91, 557\u2013568 (2010).","journal-title":"Int. J. Hematol."},{"key":"853_CR183","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/path.5001","volume":"244","author":"W Chen","year":"2018","unstructured":"Chen, W., Zhu, G., Tang, J., Zhou, H. D. & Li, Y. P. C\/ebp\u03b1 controls osteoclast terminal differentiation, activation, function, and postnatal bone homeostasis through direct regulation of Nfatc1. J. Pathol. 244, 271\u2013282 (2018).","journal-title":"J. Pathol."},{"key":"853_CR184","doi-asserted-by":"publisher","first-page":"7294","DOI":"10.1073\/pnas.1211383110","volume":"110","author":"W Chen","year":"2013","unstructured":"Chen, W. et al. C\/EBP\u03b1 regulates osteoclast lineage commitment. Proc. Natl. Acad. Sci. USA 110, 7294\u20137299 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"853_CR185","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1074\/jbc.M116.736009","volume":"293","author":"J Jules","year":"2018","unstructured":"Jules, J., Chen, W., Feng, X. & Li, Y. P. C\/EBP\u03b1 transcription factor is regulated by the RANK cytoplasmic (535)IVVY(538) motif and stimulates osteoclastogenesis more strongly than c-Fos. J. Biol. Chem. 293, 1480\u20131492 (2018).","journal-title":"J. Biol. Chem."},{"key":"853_CR186","first-page":"815","volume":"32","author":"C Chen","year":"2018","unstructured":"Chen, C., Zheng, R. Q., Cao, X. C. & Zhang, G. C. Biological characteristics of osteoclast exosomes and their role in the osteogenic differentiation of somatic cells prior to osteogenesis. J. Biol. Regul. Homeost. Agents 32, 815\u2013823 (2018).","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"853_CR187","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41413-024-00354-4","volume":"12","author":"H Kim","year":"2024","unstructured":"Kim, H. et al. SREBP2 restricts osteoclast differentiation and activity by regulating IRF7 and limits inflammatory bone erosion. Bone Res. 12, 48 (2024).","journal-title":"Bone Res."},{"key":"853_CR188","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/s41586-019-1411-0","volume":"571","author":"G Cavalli","year":"2019","unstructured":"Cavalli, G. & Heard, E. Advances in epigenetics link genetics to the environment and disease. Nature 571, 489\u2013499 (2019).","journal-title":"Nature"},{"key":"853_CR189","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1515\/cclm-2013-0770","volume":"52","author":"P Vrta\u010dnik","year":"2014","unstructured":"Vrta\u010dnik, P., Marc, J. & Ostanek, B. Epigenetic mechanisms in bone. Clin. Chem. Lab. Med. 52, 589\u2013608 (2014).","journal-title":"Clin. Chem. Lab. Med."},{"key":"853_CR190","doi-asserted-by":"crossref","unstructured":"Marini, F., Cianferotti, L. & Brandi, M. L. Epigenetic mechanisms in bone biology and osteoporosis: can they drive therapeutic choices? Int. J. Mol. Sci. 17, 1329 (2016).","DOI":"10.3390\/ijms17081329"},{"key":"853_CR191","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1021\/acs.biochem.5b01210","volume":"55","author":"R DesJarlais","year":"2016","unstructured":"DesJarlais, R. & Tummino, P. J. Role of histone-modifying enzymes and their complexes in regulation of chromatin biology. Biochemistry 55, 1584\u20131599 (2016).","journal-title":"Biochemistry"},{"key":"853_CR192","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nm.3774","volume":"21","author":"K Nishikawa","year":"2015","unstructured":"Nishikawa, K. et al. DNA methyltransferase 3a regulates osteoclast differentiation by coupling to an S-adenosylmethionine-producing metabolic pathway. Nat. Med. 21, 281\u2013287 (2015).","journal-title":"Nat. Med."},{"key":"853_CR193","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-9-r99","volume":"14","author":"L de la Rica","year":"2013","unstructured":"de la Rica, L. et al. PU.1 target genes undergo Tet2-coupled demethylation and DNMT3b-mediated methylation in monocyte-to-osteoclast differentiation. Genome Biol. 14, R99 (2013).","journal-title":"Genome Biol."},{"key":"853_CR194","doi-asserted-by":"publisher","first-page":"115471","DOI":"10.1016\/j.bone.2020.115471","volume":"138","author":"D Kurotaki","year":"2020","unstructured":"Kurotaki, D., Yoshida, H. & Tamura, T. Epigenetic and transcriptional regulation of osteoclast differentiation. Bone 138, 115471 (2020).","journal-title":"Bone"},{"key":"853_CR195","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/jbmr.3863","volume":"35","author":"J Adamik","year":"2020","unstructured":"Adamik, J. et al. EZH2 supports osteoclast differentiation and bone resorption via epigenetic and cytoplasmic targets. J. Bone Min. Res. 35, 181\u2013195 (2020).","journal-title":"J. Bone Min. Res."},{"key":"853_CR196","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1084\/jem.20160185","volume":"213","author":"Z Yang","year":"2016","unstructured":"Yang, Z., Shah, K., Khodadadi-Jamayran, A. & Jiang, H. Dpy30 is critical for maintaining the identity and function of adult hematopoietic stem cells. J. Exp. Med. 213, 2349\u20132364 (2016).","journal-title":"J. Exp. Med."},{"key":"853_CR197","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1182\/blood-2014-01-549220","volume":"124","author":"Z Yang","year":"2014","unstructured":"Yang, Z. et al. The DPY30 subunit in SET1\/MLL complexes regulates the proliferation and differentiation of hematopoietic progenitor cells. Blood 124, 2025\u20132033 (2014).","journal-title":"Blood"},{"key":"853_CR198","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.stemcr.2019.05.023","volume":"13","author":"Z Yang","year":"2019","unstructured":"Yang, Z., Shah, K., Khodadadi-Jamayran, A. & Jiang, H. Control of hematopoietic stem and progenitor cell function through epigenetic regulation of energy metabolism and genome integrity. Stem Cell Rep. 13, 61\u201375 (2019).","journal-title":"Stem Cell Rep."},{"key":"853_CR199","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2022.116379","volume":"159","author":"Y Zhao","year":"2022","unstructured":"Zhao, Y. et al. Role of chromatin modulator Dpy30 in osteoclast differentiation and function. Bone 159, 116379 (2022).","journal-title":"Bone"},{"key":"853_CR200","doi-asserted-by":"publisher","first-page":"E10137","DOI":"10.1073\/pnas.1806019115","volume":"115","author":"P Das","year":"2018","unstructured":"Das, P. et al. Histone methylation regulator PTIP is required to maintain normal and leukemic bone marrow niches. Proc. Natl. Acad. Sci. USA 115, E10137\u2013E10146 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"853_CR201","doi-asserted-by":"publisher","DOI":"10.1038\/srep21131","volume":"6","author":"A Robaszkiewicz","year":"2016","unstructured":"Robaszkiewicz, A. et al. ARTD1 regulates osteoclastogenesis and bone homeostasis by dampening NF-\u03baB-dependent transcription of IL-1\u03b2. Sci. Rep. 6, 21131 (2016).","journal-title":"Sci. Rep."},{"key":"853_CR202","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1182\/bloodadvances.2018018309","volume":"2","author":"N Rohatgi","year":"2018","unstructured":"Rohatgi, N. et al. ASXL1 impairs osteoclast formation by epigenetic regulation of NFATc1. Blood Adv. 2, 2467\u20132477 (2018).","journal-title":"Blood Adv."},{"key":"853_CR203","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nsmb1128","volume":"13","author":"Y Dou","year":"2006","unstructured":"Dou, Y. et al. Regulation of MLL1 H3K4 methyltransferase activity by its core components. Nat. Struct. Mol. Biol. 13, 713\u2013719 (2006).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"853_CR204","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1038\/nsmb.2656","volume":"20","author":"H Jiang","year":"2013","unstructured":"Jiang, H. et al. Regulation of transcription by the MLL2 complex and MLL complex-associated AKAP95. Nat. Struct. Mol. Biol. 20, 1156\u20131163 (2013).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"853_CR205","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202403177","volume":"11","author":"W Chu","year":"2024","unstructured":"Chu, W. et al. PRMT6 epigenetically drives metabolic switch from fatty acid oxidation toward glycolysis and promotes osteoclast differentiation during osteoporosis. Adv. Sci. 11, e2403177 (2024).","journal-title":"Adv. Sci."},{"key":"853_CR206","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1042\/bj20021321","volume":"370","author":"AJ de Ruijter","year":"2003","unstructured":"de Ruijter, A. J., van Gennip, A. H., Caron, H. N., Kemp, S. & van Kuilenburg, A. B. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem. J. 370, 737\u2013749 (2003).","journal-title":"Biochem. J."},{"key":"853_CR207","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.3390\/molecules24071355","volume":"24","author":"B Faulkner","year":"2019","unstructured":"Faulkner, B., Astleford, K. & Mansky, K. C. Regulation of osteoclast differentiation and skeletal maintenance by histone deacetylases. Molecules 24, 1355 (2019).","journal-title":"Molecules"},{"key":"853_CR208","doi-asserted-by":"publisher","first-page":"C780","DOI":"10.1152\/ajpcell.00351.2015","volume":"310","author":"C Dou","year":"2016","unstructured":"Dou, C. et al. HDAC2 regulates FoxO1 during RANKL-induced osteoclastogenesis. Am. J. Physiol. Cell Physiol. 310, C780\u2013C787 (2016).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"853_CR209","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1182\/blood-2002-08-2622","volume":"101","author":"MM Rahman","year":"2003","unstructured":"Rahman, M. M. et al. Two histone deacetylase inhibitors, trichostatin A and sodium butyrate, suppress differentiation into osteoclasts but not into macrophages. Blood 101, 3451\u20133459 (2003).","journal-title":"Blood"},{"key":"853_CR210","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ejphar.2009.09.025","volume":"623","author":"HN Kim","year":"2009","unstructured":"Kim, H. N. et al. Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL. Eur. J. Pharm. 623, 22\u201329 (2009).","journal-title":"Eur. J. Pharm."},{"key":"853_CR211","doi-asserted-by":"publisher","first-page":"e0185441","DOI":"10.1371\/journal.pone.0185441","volume":"12","author":"NC Blixt","year":"2017","unstructured":"Blixt, N. C. et al. Class II and IV HDACs function as inhibitors of osteoclast differentiation. PLoS One 12, e0185441 (2017).","journal-title":"PLoS One"},{"key":"853_CR212","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/jbmr.2381","volume":"30","author":"MN Wein","year":"2015","unstructured":"Wein, M. N. et al. HDAC5 controls MEF2C-driven sclerostin expression in osteocytes. J. Bone Min. Res. 30, 400\u2013411 (2015).","journal-title":"J. Bone Min. Res."},{"key":"853_CR213","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1242\/jcs.02425","volume":"118","author":"O Destaing","year":"2005","unstructured":"Destaing, O. et al. A novel Rho-mDia2-HDAC6 pathway controls podosome patterning through microtubule acetylation in osteoclasts. J. Cell Sci. 118, 2901\u20132911 (2005).","journal-title":"J. Cell Sci."},{"key":"853_CR214","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1242\/jcs.046813","volume":"122","author":"Y Zilberman","year":"2009","unstructured":"Zilberman, Y. et al. Regulation of microtubule dynamics by inhibition of the tubulin deacetylase HDAC6. J. Cell Sci. 122, 3531\u20133541 (2009).","journal-title":"J. Cell Sci."},{"key":"853_CR215","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1101\/gad.1467506","volume":"20","author":"MC Haigis","year":"2006","unstructured":"Haigis, M. C. & Guarente, L. P. Mammalian sirtuins\u2013emerging roles in physiology, aging, and calorie restriction. Genes Dev. 20, 2913\u20132921 (2006).","journal-title":"Genes Dev."},{"key":"853_CR216","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1002\/art.37963","volume":"65","author":"HS Lee","year":"2013","unstructured":"Lee, H. S. et al. Overexpression of sirtuin 6 suppresses inflammatory responses and bone destruction in mice with collagen-induced arthritis. Arthritis. Rheum. 65, 1776\u20131785 (2013).","journal-title":"Arthritis. Rheum."},{"key":"853_CR217","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117231","volume":"178","author":"J Liu","year":"2024","unstructured":"Liu, J. et al. Osteoclast-derived exosomes influence osteoblast differentiation in osteoporosis progression via the lncRNA AW011738\/miR-24-2-5p\/TREM1 axis. Biomed. Pharmacother. 178, 117231 (2024).","journal-title":"Biomed. Pharmacother."},{"key":"853_CR218","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nature11000","volume":"485","author":"M Hayashi","year":"2012","unstructured":"Hayashi, M. et al. Osteoprotection by semaphorin 3A. Nature 485, 69\u201374 (2012).","journal-title":"Nature"},{"key":"853_CR219","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.bone.2013.07.007","volume":"56","author":"Y Lee","year":"2013","unstructured":"Lee, Y. et al. MicroRNA-124 regulates osteoclast differentiation. Bone 56, 383\u2013389 (2013).","journal-title":"Bone"},{"key":"853_CR220","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2024.117323","volume":"190","author":"S Minami","year":"2025","unstructured":"Minami, S. et al. Extracellular vesicles from mouse bone marrow macrophages-derived osteoclasts treated with zoledronic acid contain miR-146a-5p and miR-322-3p, which inhibit osteoclast function. Bone 190, 117323 (2025).","journal-title":"Bone"},{"key":"853_CR221","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.bone.2018.08.014","volume":"116","author":"OJ Sul","year":"2018","unstructured":"Sul, O. J. et al. MicroRNA-155 induces autophagy in osteoclasts by targeting transforming growth factor \u03b2-activated kinase 1-binding protein 2 upon lipopolysaccharide stimulation. Bone 116, 279\u2013289 (2018).","journal-title":"Bone"},{"key":"853_CR222","doi-asserted-by":"crossref","unstructured":"Sugatani, T. & Hruska, K. A. MicroRNA-223 is a key factor in osteoclast differentiation. J. Cell. Biochem. 101, 996\u2013999 (2007).","DOI":"10.1002\/jcb.21335"},{"key":"853_CR223","doi-asserted-by":"crossref","unstructured":"He, J. et al. FTO regulates osteoclast development by modulating the proliferation and apoptosis of osteoclast precursors in inflammatory conditions. Cell Signal. 117, 111098 (2024).","DOI":"10.1016\/j.cellsig.2024.111098"},{"key":"853_CR224","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00418-018-1636-2","volume":"149","author":"T Ono","year":"2018","unstructured":"Ono, T. & Nakashima, T. Recent advances in osteoclast biology. Histochem. Cell Biol. 149, 325\u2013341 (2018).","journal-title":"Histochem. Cell Biol."},{"key":"853_CR225","doi-asserted-by":"publisher","first-page":"8912","DOI":"10.3390\/ijms14058912","volume":"14","author":"HH Park","year":"2013","unstructured":"Park, H. H. Structural basis of membrane trafficking by Rab family small G protein. Int. J. Mol. Sci. 14, 8912\u20138923 (2013).","journal-title":"Int. J. Mol. Sci."},{"key":"853_CR226","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1083\/jcb.200611083","volume":"176","author":"W Zou","year":"2007","unstructured":"Zou, W. et al. Syk, c-Src, the alphavbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption. J. Cell Biol. 176, 877\u2013888 (2007).","journal-title":"J. Cell Biol."},{"key":"853_CR227","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.0105-2896.2005.00331.x","volume":"208","author":"FP Ross","year":"2005","unstructured":"Ross, F. P. & Teitelbaum, S. L. alphavbeta3 and macrophage colony-stimulating factor: partners in osteoclast biology. Immunol. Rev. 208, 88\u2013105 (2005).","journal-title":"Immunol. Rev."},{"key":"853_CR228","doi-asserted-by":"publisher","first-page":"21971","DOI":"10.1074\/jbc.M200434200","volume":"277","author":"D Cappellen","year":"2002","unstructured":"Cappellen, D. et al. Transcriptional program of mouse osteoclast differentiation governed by the macrophage colony-stimulating factor and the ligand for the receptor activator of NFkappa B. J. Biol. Chem. 277, 21971\u201321982 (2002).","journal-title":"J. Biol. Chem."},{"key":"853_CR229","doi-asserted-by":"publisher","first-page":"26393","DOI":"10.1074\/jbc.274.37.26393","volume":"274","author":"TW Kelley","year":"1999","unstructured":"Kelley, T. W. et al. Macrophage colony-stimulating factor promotes cell survival through Akt\/protein kinase B. J. Biol. Chem. 274, 26393\u201326398 (1999).","journal-title":"J. Biol. Chem."},{"key":"853_CR230","first-page":"2021","volume":"163","author":"E Grimaud","year":"2003","unstructured":"Grimaud, E. et al. Receptor activator of nuclear factor kappaB ligand (RANKL)\/osteoprotegerin (OPG) ratio is increased in severe osteolysis. Am. J. Pathol. 163, 2021\u20132031 (2003).","journal-title":"J. Pathol."},{"key":"853_CR231","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1101\/gad.13.18.2412","volume":"13","author":"WC Dougall","year":"1999","unstructured":"Dougall, W. C. et al. RANK is essential for osteoclast and lymph node development. Genes Dev. 13, 2412\u20132424 (1999).","journal-title":"Genes Dev."},{"key":"853_CR232","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4068\/cmj.2016.52.1.12","volume":"52","author":"JH Kim","year":"2016","unstructured":"Kim, J. H. & Kim, N. Signaling pathways in osteoclast differentiation. Chonnam Med. J. 52, 12\u201317 (2016).","journal-title":"Chonnam Med. J."},{"key":"853_CR233","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1073\/pnas.97.4.1566","volume":"97","author":"J Li","year":"2000","unstructured":"Li, J. et al. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc. Natl. Acad. Sci. USA 97, 1566\u20131571 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"853_CR234","doi-asserted-by":"publisher","first-page":"987","DOI":"10.2353\/ajpath.2006.060180","volume":"169","author":"T Kawai","year":"2006","unstructured":"Kawai, T. et al. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am. J. Pathol. 169, 987\u2013998 (2006).","journal-title":"Am. J. Pathol."},{"key":"853_CR235","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1359\/jbmr.0301213","volume":"19","author":"P Valverde","year":"2004","unstructured":"Valverde, P., Kawai, T. & Taubman, M. A. Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease. J. Bone Min. Res. 19, 155\u2013164 (2004).","journal-title":"J. Bone Min. Res."},{"key":"853_CR236","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1093\/rheumatology\/ken363","volume":"47","author":"M Hashizume","year":"2008","unstructured":"Hashizume, M., Hayakawa, N. & Mihara, M. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17. Rheumatology 47, 1635\u20131640 (2008).","journal-title":"Rheumatology"},{"key":"853_CR237","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S8756-3282(01)00420-3","volume":"28","author":"M Komine","year":"2001","unstructured":"Komine, M. et al. Tumor necrosis factor-alpha cooperates with receptor activator of nuclear factor kappaB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture. Bone 28, 474\u2013483 (2001).","journal-title":"Bone"},{"key":"853_CR238","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00198-019-04874-2","volume":"30","author":"D Saribal","year":"2019","unstructured":"Saribal, D. et al. Inflammatory cytokines IL-6 and TNF-\u03b1 in patients with hip fracture. Osteoporos. Int. 30, 1025\u20131031 (2019).","journal-title":"Osteoporos. Int."},{"key":"853_CR239","doi-asserted-by":"publisher","first-page":"15728","DOI":"10.1074\/jbc.M111.296228","volume":"287","author":"J Jules","year":"2012","unstructured":"Jules, J. et al. Molecular basis of requirement of receptor activator of nuclear factor \u03baB signaling for interleukin 1-mediated osteoclastogenesis. J. Biol. Chem. 287, 15728\u201315738 (2012).","journal-title":"J. Biol. Chem."},{"key":"853_CR240","doi-asserted-by":"publisher","first-page":"37427","DOI":"10.1074\/jbc.M110.149484","volume":"285","author":"J Jules","year":"2010","unstructured":"Jules, J. et al. Receptor activator of NF-{kappa}B (RANK) cytoplasmic IVVY535-538 motif plays an essential role in tumor necrosis factor-{alpha} (TNF)-mediated osteoclastogenesis. J. Biol. Chem. 285, 37427\u201337435 (2010).","journal-title":"J. Biol. Chem."},{"key":"853_CR241","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.1074\/jbc.M510383200","volume":"281","author":"D Xu","year":"2006","unstructured":"Xu, D., Wang, S., Liu, W., Liu, J. & Feng, X. A novel receptor activator of NF-kappaB (RANK) cytoplasmic motif plays an essential role in osteoclastogenesis by committing macrophages to the osteoclast lineage. J. Biol. Chem. 281, 4678\u20134690 (2006).","journal-title":"J. Biol. Chem."},{"key":"853_CR242","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1111\/j.1365-2443.2009.01351.x","volume":"14","author":"Y Taguchi","year":"2009","unstructured":"Taguchi, Y., Gohda, J., Koga, T., Takayanagi, H. & Inoue, J. A unique domain in RANK is required for Gab2 and PLCgamma2 binding to establish osteoclastogenic signals. Genes Cells 14, 1331\u20131345 (2009).","journal-title":"Genes Cells"},{"key":"853_CR243","doi-asserted-by":"publisher","first-page":"23738","DOI":"10.1074\/jbc.M115.667535","volume":"290","author":"J Jules","year":"2015","unstructured":"Jules, J. et al. The IVVY motif and tumor necrosis factor receptor-associated factor (TRAF) sites in the cytoplasmic domain of the receptor activator of nuclear factor \u03baB (RANK) cooperate to induce osteoclastogenesis. J. Biol. Chem. 290, 23738\u201323750 (2015).","journal-title":"J. Biol. Chem."},{"key":"853_CR244","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/jbmr.3342","volume":"33","author":"W Chen","year":"2018","unstructured":"Chen, W., Zhu, G., Jules, J., Nguyen, D. & Li, Y. P. Monocyte-specific knockout of C\/ebp\u03b1 results in osteopetrosis phenotype, blocks bone loss in ovariectomized mice, and reveals an important function of C\/ebp\u03b1 in osteoclast differentiation and function. J. Bone Min. Res. 33, 691\u2013703 (2018).","journal-title":"J. Bone Min. Res."},{"key":"853_CR245","doi-asserted-by":"publisher","first-page":"5057","DOI":"10.1172\/JCI71882","volume":"124","author":"S Li","year":"2014","unstructured":"Li, S. et al. RBP-J imposes a requirement for ITAM-mediated costimulation of osteoclastogenesis. J. Clin. Invest. 124, 5057\u20135073 (2014).","journal-title":"J. Clin. Invest."},{"key":"853_CR246","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13700","volume":"8","author":"M Wu","year":"2017","unstructured":"Wu, M. et al. G\u03b113 negatively controls osteoclastogenesis through inhibition of the Akt-GSK3\u03b2-NFATc1 signalling pathway. Nat. Commun. 8, 13700 (2017).","journal-title":"Nat. Commun."},{"key":"853_CR247","doi-asserted-by":"publisher","first-page":"903657","DOI":"10.3389\/fcell.2022.903657","volume":"10","author":"L Marcadet","year":"2022","unstructured":"Marcadet, L., Bouredji, Z., Argaw, A. & Frenette, J. The roles of RANK\/RANKL\/OPG in cardiac, skeletal, and smooth muscles in health and disease. Front. Cell Dev. Biol. 10, 903657 (2022).","journal-title":"Front. Cell Dev. Biol."},{"key":"853_CR248","first-page":"ziae029","volume":"8","author":"R Clark","year":"2024","unstructured":"Clark, R., Park, S. Y., Bradley, E. W., Mansky, K. & Tasca, A. Mouse mandibular-derived osteoclast progenitors have differences in intrinsic properties compared with femoral-derived progenitors. JBMR 8, ziae029 (2024).","journal-title":"JBMR"},{"key":"853_CR249","doi-asserted-by":"publisher","first-page":"101043","DOI":"10.1016\/j.mtbio.2024.101043","volume":"26","author":"X Cheng","year":"2024","unstructured":"Cheng, X., Tian, W., Yang, J., Wang, J. & Zhang, Y. Engineering approaches to manipulate osteoclast behavior for bone regeneration. Mater. Today Bio 26, 101043 (2024).","journal-title":"Mater. Today Bio"},{"key":"853_CR250","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00774-020-01162-6","volume":"39","author":"N Udagawa","year":"2021","unstructured":"Udagawa, N. et al. Osteoclast differentiation by RANKL and OPG signaling pathways. J. Bone Min. Metab. 39, 19\u201326 (2021).","journal-title":"J. Bone Min. Metab."},{"key":"853_CR251","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.82118","volume":"12","author":"K Inoue","year":"2023","unstructured":"Inoue, K. et al. Bone marrow Adipoq-lineage progenitors are a major cellular source of M-CSF that dominates bone marrow macrophage development, osteoclastogenesis, and bone mass. Elife 12, e82118 (2023).","journal-title":"Elife"},{"key":"853_CR252","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.82112","volume":"12","author":"L Zhong","year":"2023","unstructured":"Zhong, L. et al. Csf1 from marrow adipogenic precursors is required for osteoclast formation and hematopoiesis in bone. Elife 12, e82112 (2023).","journal-title":"Elife"},{"key":"853_CR253","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0083-6729(06)74015-8","volume":"74","author":"I Nakamura","year":"2006","unstructured":"Nakamura, I. & Jimi, E. Regulation of osteoclast differentiation and function by interleukin-1. Vitam. Horm. 74, 357\u2013370 (2006).","journal-title":"Vitam. Horm."},{"key":"853_CR254","doi-asserted-by":"publisher","first-page":"8163","DOI":"10.3390\/ijms25158163","volume":"25","author":"A Dawalibi","year":"2024","unstructured":"Dawalibi, A., Alosaimi, A. A. & Mohammad, K. S. Balancing the scales: the dual role of interleukins in bone metastatic microenvironments. Int. J. Mol. Sci. 25, 8163 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"853_CR255","doi-asserted-by":"publisher","DOI":"10.4110\/in.2018.18.e8","volume":"18","author":"DS Amarasekara","year":"2018","unstructured":"Amarasekara, D. S. et al. Regulation of osteoclast differentiation by cytokine networks. Immune Netw. 18, e8 (2018).","journal-title":"Immune Netw."},{"key":"853_CR256","doi-asserted-by":"crossref","unstructured":"Gao, X., Ge, J., Zhou, W., Xu, L. & Geng, D. IL-10 inhibits osteoclast differentiation and osteolysis through MEG3\/IRF8 pathway. Cell Signal. 95, 110353 (2022).","DOI":"10.1016\/j.cellsig.2022.110353"},{"key":"853_CR257","doi-asserted-by":"publisher","first-page":"6097","DOI":"10.4049\/jimmunol.1003487","volume":"186","author":"MM Zaiss","year":"2011","unstructured":"Zaiss, M. M. et al. IL-33 shifts the balance from osteoclast to alternatively activated macrophage differentiation and protects from TNF-alpha-mediated bone loss. J. Immunol. 186, 6097\u20136105 (2011).","journal-title":"J. Immunol."},{"key":"853_CR258","doi-asserted-by":"publisher","first-page":"142","DOI":"10.4049\/jimmunol.171.1.142","volume":"171","author":"SM Khapli","year":"2003","unstructured":"Khapli, S. M., Mangashetti, L. S., Yogesha, S. D. & Wani, M. R. IL-3 acts directly on osteoclast precursors and irreversibly inhibits receptor activator of NF-kappa B ligand-induced osteoclast differentiation by diverting the cells to macrophage lineage. J. Immunol. 171, 142\u2013151 (2003).","journal-title":"J. Immunol."},{"key":"853_CR259","doi-asserted-by":"publisher","first-page":"11759","DOI":"10.1074\/jbc.M410828200","volume":"280","author":"SD Yogesha","year":"2005","unstructured":"Yogesha, S. D., Khapli, S. M. & Wani, M. R. Interleukin-3 and granulocyte-macrophage colony-stimulating factor inhibits tumor necrosis factor (TNF)-alpha-induced osteoclast differentiation by down-regulation of expression of TNF receptors 1 and 2. J. Biol. Chem. 280, 11759\u201311769 (2005).","journal-title":"J. Biol. Chem."},{"key":"853_CR260","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12038-021-00181-3","volume":"46","author":"V Piprode","year":"2021","unstructured":"Piprode, V., Singh, K., Kumar, A., Josh, S. R. & Wani, M. R. IL-3 inhibits rat osteoclast differentiation induced by TNF-\u03b1 and other pro-osteoclastogenic cytokines. J. Biosci. 46, 63 (2021).","journal-title":"J. Biosci."},{"key":"853_CR261","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1084\/jem.191.2.275","volume":"191","author":"K Kobayashi","year":"2000","unstructured":"Kobayashi, K. et al. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF\/RANKL-RANK interaction. J. Exp. Med. 191, 275\u2013286 (2000).","journal-title":"J. Exp. Med."},{"key":"853_CR262","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.4049\/jimmunol.0803007","volume":"183","author":"JH Kim","year":"2009","unstructured":"Kim, J. H. et al. The mechanism of osteoclast differentiation induced by IL-1. J. Immunol. 183, 1862\u20131870 (2009).","journal-title":"J. Immunol."},{"key":"853_CR263","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1126\/science.1172702","volume":"326","author":"A Chaudhry","year":"2009","unstructured":"Chaudhry, A. et al. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 326, 986\u2013991 (2009).","journal-title":"Science"},{"key":"853_CR264","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1136\/ard.2007.086066","volume":"68","author":"H Kelchtermans","year":"2009","unstructured":"Kelchtermans, H. et al. Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis. Ann. Rheum. Dis. 68, 744\u2013750 (2009).","journal-title":"Ann. Rheum. Dis."},{"key":"853_CR265","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.bbrc.2007.04.042","volume":"357","author":"YG Kim","year":"2007","unstructured":"Kim, Y. G. et al. Human CD4+CD25+ regulatory T cells inhibit the differentiation of osteoclasts from peripheral blood mononuclear cells. Biochem. Biophys. Res. Commun. 357, 1046\u20131052 (2007).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"853_CR266","doi-asserted-by":"publisher","first-page":"4104","DOI":"10.1002\/art.23138","volume":"56","author":"MM Zaiss","year":"2007","unstructured":"Zaiss, M. M. et al. Treg cells suppress osteoclast formation: a new link between the immune system and bone. Arthritis Rheum. 56, 4104\u20134112 (2007).","journal-title":"Arthritis Rheum."},{"key":"853_CR267","doi-asserted-by":"publisher","DOI":"10.1172\/JCI141008","volume":"131","author":"A Levescot","year":"2021","unstructured":"Levescot, A. et al. IL-1\u03b2-driven osteoclastogenic Tregs accelerate bone erosion in arthritis. J. Clin. Invest. 131, e141008 (2021).","journal-title":"J. Clin. Invest."},{"key":"853_CR268","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1159\/000465455","volume":"41","author":"Q Wu","year":"2017","unstructured":"Wu, Q., Zhou, X., Huang, D., Ji, Y. & Kang, F. IL-6 enhances osteocyte-mediated osteoclastogenesis by promoting JAK2 and RANKL activity in vitro. Cell Physiol. Biochem. 41, 1360\u20131369 (2017).","journal-title":"Cell Physiol. Biochem."},{"key":"853_CR269","doi-asserted-by":"publisher","first-page":"19301","DOI":"10.1074\/jbc.274.27.19301","volume":"274","author":"CA O\u2019Brien","year":"1999","unstructured":"O\u2019Brien, C. A., Gubrij, I., Lin, S. C., Saylors, R. L. & Manolagas, S. C. STAT3 activation in stromal\/osteoblastic cells is required for induction of the receptor activator of NF-kappaB ligand and stimulation of osteoclastogenesis by gp130-utilizing cytokines or interleukin-1 but not 1,25-dihydroxyvitamin D3 or parathyroid hormone. J. Biol. Chem. 274, 19301\u201319308 (1999).","journal-title":"J. Biol. Chem."},{"key":"853_CR270","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/cpt.782","volume":"102","author":"S Rose-John","year":"2017","unstructured":"Rose-John, S. The soluble interleukin 6 receptor: advanced therapeutic options in inflammation. Clin. Pharm. Ther. 102, 591\u2013598 (2017).","journal-title":"Clin. Pharm. Ther."},{"key":"853_CR271","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.3390\/ijms20061467","volume":"20","author":"HJ Kim","year":"2019","unstructured":"Kim, H. J. et al. Zoledronate enhances osteocyte-mediated osteoclast differentiation by IL-6\/RANKL axis. Int. J. Mol. Sci. 20, 1467 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"853_CR272","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s10735-022-10077-7","volume":"53","author":"W Feng","year":"2022","unstructured":"Feng, W., Yang, P., Liu, H., Zhang, F. & Li, M. IL-6 promotes low concentration of RANKL-induced osteoclastic differentiation by mouse BMMs through trans-signaling pathway. J. Mol. Histol. 53, 599\u2013610 (2022).","journal-title":"J. Mol. Histol."},{"key":"853_CR273","doi-asserted-by":"publisher","first-page":"13453","DOI":"10.1073\/pnas.95.23.13453","volume":"95","author":"P Saftig","year":"1998","unstructured":"Saftig, P. et al. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc. Natl. Acad. Sci. USA 95, 13453\u201313458 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"853_CR274","doi-asserted-by":"publisher","first-page":"5522","DOI":"10.7150\/ijbs.72211","volume":"18","author":"G Zhu","year":"2022","unstructured":"Zhu, G. et al. Knockout and double knockout of cathepsin K and Mmp9 reveals a novel function of cathepsin K as a regulator of osteoclast gene expression and bone homeostasis. Int. J. Biol. Sci. 18, 5522\u20135538 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"853_CR275","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1359\/jbmr.2001.16.6.1136","volume":"16","author":"W Deng","year":"2001","unstructured":"Deng, W. et al. Characterization of mouse Atp6i gene, the gene promoter, and the gene expression. J. Bone Min. Res. 16, 1136\u20131146 (2001).","journal-title":"J. Bone Min. Res."},{"key":"853_CR276","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/70563","volume":"23","author":"YP Li","year":"1999","unstructured":"Li, Y. P., Chen, W., Liang, Y., Li, E. & Stashenko, P. Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification. Nat. Genet. 23, 447\u2013451 (1999).","journal-title":"Nat. Genet."},{"key":"853_CR277","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1006\/bbrc.1996.0145","volume":"218","author":"YP Li","year":"1996","unstructured":"Li, Y. P., Chen, W. & Stashenko, P. Molecular cloning and characterization of a putative novel human osteoclast-specific 116-kDa vacuolar proton pump subunit. Biochem. Biophys. Res. Commun. 218, 813\u2013821 (1996).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"853_CR278","doi-asserted-by":"publisher","first-page":"47675","DOI":"10.18632\/oncotarget.17544","volume":"8","author":"M McConnell","year":"2017","unstructured":"McConnell, M. et al. Osteoclast proton pump regulator Atp6v1c1 enhances breast cancer growth by activating the mTORC1 pathway and bone metastasis by increasing V-ATPase activity. Oncotarget 8, 47675\u201347690 (2017).","journal-title":"Oncotarget"},{"key":"853_CR279","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1042\/BJ20081073","volume":"417","author":"S Feng","year":"2009","unstructured":"Feng, S. et al. Atp6v1c1 is an essential component of the osteoclast proton pump and in F-actin ring formation in osteoclasts. Biochem. J. 417, 195\u2013203 (2009).","journal-title":"Biochem. J."},{"key":"853_CR280","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1002\/jbmr.1623","volume":"27","author":"DQ Yang","year":"2012","unstructured":"Yang, D. Q. et al. V-ATPase subunit ATP6AP1 (Ac45) regulates osteoclast differentiation, extracellular acidification, lysosomal trafficking, and protease exocytosis in osteoclast-mediated bone resorption. J. Bone Min. Res. 27, 1695\u20131707 (2012).","journal-title":"J. Bone Min. Res."},{"key":"853_CR281","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41368-023-00235-2","volume":"15","author":"J Wang","year":"2023","unstructured":"Wang, J. et al. Atp6i deficient mouse model uncovers transforming growth factor-\u03b21\/Smad2\/3 as a key signaling pathway regulating odontoblast differentiation and tooth root formation. Int. J. Oral. Sci. 15, 35 (2023).","journal-title":"Int. J. Oral. Sci."},{"key":"853_CR282","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1359\/jbmr.081239","volume":"24","author":"H Wu","year":"2009","unstructured":"Wu, H., Xu, G. & Li, Y. P. Atp6v0d2 is an essential component of the osteoclast-specific proton pump that mediates extracellular acidification in bone resorption. J. Bone Min. Res. 24, 871\u2013885 (2009).","journal-title":"J. Bone Min. Res."},{"key":"853_CR283","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00774-007-0773-9","volume":"25","author":"I Nakamura","year":"2007","unstructured":"Nakamura, I., Duong, L. T., Rodan, S. B. & Rodan, G. A. Involvement of alpha(v)beta3 integrins in osteoclast function. J. Bone Min. Metab. 25, 337\u2013344 (2007).","journal-title":"J. Bone Min. Metab."},{"key":"853_CR284","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1091\/mbc.e11-03-0193","volume":"22","author":"K Laulagnier","year":"2011","unstructured":"Laulagnier, K. et al. Role of AP1 and Gadkin in the traffic of secretory endo-lysosomes. Mol. Biol. Cell 22, 2068\u20132082 (2011).","journal-title":"Mol. Biol. Cell"},{"key":"853_CR285","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.bbrc.2022.09.065","volume":"632","author":"F Hiura","year":"2022","unstructured":"Hiura, F., Kawabata, Y., Aoki, T., Mizokami, A. & Jimi, E. Inhibition of the ATG4-LC3 pathway suppressed osteoclast maturation. Biochem. Biophys. Res. Commun. 632, 40\u201347 (2022).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"853_CR286","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Cui, Y., Wang, L. & Han, J. Autophagy promotes osteoclast podosome disassembly and cell motility athrough the interaction of kindlin3 with LC3. Cell Signal. 67, 109505 (2020).","DOI":"10.1016\/j.cellsig.2019.109505"},{"key":"853_CR287","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02533-2","volume":"7","author":"EL Stattin","year":"2017","unstructured":"Stattin, E. L. et al. SNX10 gene mutation leading to osteopetrosis with dysfunctional osteoclasts. Sci. Rep. 7, 3012 (2017).","journal-title":"Sci. Rep."},{"key":"853_CR288","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1016\/j.devcel.2022.09.013","volume":"57","author":"M Li","year":"2022","unstructured":"Li, M. et al. Gasdermin D maintains bone mass by rewiring the endo-lysosomal pathway of osteoclastic bone resorption. Dev. Cell 57, 2365\u20132380.e8 (2022).","journal-title":"Dev. Cell"},{"key":"853_CR289","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.2741\/1750","volume":"10","author":"KU Ogbureke","year":"2005","unstructured":"Ogbureke, K. U., Zhao, Q. & Li, Y. P. Human osteopetroses and the osteoclast V-H+-ATPase enzyme system. Front. Biosci. 10, 2940\u20132954 (2005).","journal-title":"Front. Biosci."},{"key":"853_CR290","doi-asserted-by":"publisher","first-page":"16009","DOI":"10.1038\/boneres.2016.9","volume":"4","author":"M Wu","year":"2016","unstructured":"Wu, M., Chen, G. & Li, Y. P. TGF-\u03b2 and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease. Bone Res. 4, 16009 (2016).","journal-title":"Bone Res."},{"key":"853_CR291","doi-asserted-by":"publisher","first-page":"869422","DOI":"10.3389\/fimmu.2022.869422","volume":"13","author":"T Bordukalo-Nik\u0161i\u0107","year":"2022","unstructured":"Bordukalo-Nik\u0161i\u0107, T., Kufner, V. & Vuki\u010devi\u0107, S. The role Of BMPs in the regulation of osteoclasts resorption and bone remodeling: from experimental models to clinical applications. Front. Immunol. 13, 869422 (2022).","journal-title":"Front. Immunol."},{"key":"853_CR292","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41413-024-00338-4","volume":"12","author":"B Krishnacoumar","year":"2024","unstructured":"Krishnacoumar, B. et al. Caspase-8 promotes scramblase-mediated phosphatidylserine exposure and fusion of osteoclast precursors. Bone Res. 12, 40 (2024).","journal-title":"Bone Res."},{"key":"853_CR293","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1902\/jop.2015.140643","volume":"86","author":"L Hao","year":"2015","unstructured":"Hao, L. et al. Odanacatib, a cathepsin K-specific inhibitor, inhibits inflammation and bone loss caused by periodontal diseases. J. Periodontol. 86, 972\u2013983 (2015).","journal-title":"J. Periodontol."},{"key":"853_CR294","doi-asserted-by":"publisher","first-page":"781272","DOI":"10.3389\/fgene.2021.781272","volume":"12","author":"SM Toor","year":"2021","unstructured":"Toor, S. M., Wani, S. & Albagha, O. M. E. Comprehensive transcriptomic profiling of murine osteoclast differentiation reveals novel differentially expressed genes and lncRNAs. Front. Genet. 12, 781272 (2021).","journal-title":"Front. Genet."},{"key":"853_CR295","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00198-010-1272-8","volume":"22","author":"JC Crockett","year":"2011","unstructured":"Crockett, J. C., Mellis, D. J., Scott, D. I. & Helfrich, M. H. New knowledge on critical osteoclast formation and activation pathways from study of rare genetic diseases of osteoclasts: focus on the RANK\/RANKL axis. Osteoporos. Int. 22, 1\u201320 (2011).","journal-title":"Osteoporos. Int."},{"key":"853_CR296","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.3390\/antiox13121575","volume":"13","author":"E Sakai","year":"2024","unstructured":"Sakai, E. & Tsukuba, T. Transcriptomic characterization reveals mitochondrial involvement in Nrf2\/Keap1-mediated osteoclastogenesis. Antioxidants 13, 1575 (2024).","journal-title":"Antioxidants"},{"key":"853_CR297","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1210\/edrv.20.3.0367","volume":"20","author":"T Suda","year":"1999","unstructured":"Suda, T. et al. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20, 345\u2013357 (1999).","journal-title":"Endocr. Rev."},{"key":"853_CR298","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3389\/fendo.2019.00277","volume":"10","author":"RD Maynard","year":"2019","unstructured":"Maynard, R. D. & Ackert-Bicknell, C. L. Mouse models and online resources for functional analysis of osteoporosis genome-wide association studies. Front. Endocrinol. 10, 277 (2019).","journal-title":"Front. Endocrinol."},{"key":"853_CR299","first-page":"ziae112","volume":"8","author":"S Aksornthong","year":"2024","unstructured":"Aksornthong, S., Patel, P. & Komarova, S. V. Osteoclast indices in osteogenesis imperfecta: systematic review and meta-analysis. JBMR 8, ziae112 (2024).","journal-title":"JBMR"},{"key":"853_CR300","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/jbmr.3378","volume":"33","author":"M Pata","year":"2018","unstructured":"Pata, M. & Vacher, J. Ostm1 bifunctional roles in osteoclast maturation: insights from a mouse model mimicking a human OSTM1 mutation. J. Bone Min. Res. 33, 888\u2013898 (2018).","journal-title":"J. Bone Min. Res."},{"key":"853_CR301","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03046-z","volume":"11","author":"J Guo","year":"2020","unstructured":"Guo, J. et al. PERK controls bone homeostasis through the regulation of osteoclast differentiation and function. Cell Death Dis. 11, 847 (2020).","journal-title":"Cell Death Dis."},{"key":"853_CR302","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41413-023-00293-6","volume":"11","author":"S Yang","year":"2023","unstructured":"Yang, S., He, Z., Wu, T., Wang, S. & Dai, H. Glycobiology in osteoclast differentiation and function. Bone Res. 11, 55 (2023).","journal-title":"Bone Res."},{"key":"853_CR303","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.3390\/ijms23031786","volume":"23","author":"MA Terkawi","year":"2022","unstructured":"Terkawi, M. A. et al. Interplay between inflammation and pathological bone resorption: insights into recent mechanisms and pathways in related diseases for future perspectives. Int. J. Mol. Sci. 23, 1786 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"853_CR304","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1007\/s11914-023-00824-4","volume":"21","author":"HM Torres","year":"2023","unstructured":"Torres, H. M., Arnold, K. M., Oviedo, M., Westendorf, J. J. & Weaver, S. R. Inflammatory processes affecting bone health and repair. Curr. Osteoporos. Rep. 21, 842\u2013853 (2023).","journal-title":"Curr. Osteoporos. Rep."},{"key":"853_CR305","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41413-024-00346-4","volume":"12","author":"B Mi","year":"2024","unstructured":"Mi, B. et al. Ageing-related bone and immunity changes: insights into the complex interplay between the skeleton and the immune system. Bone Res. 12, 42 (2024).","journal-title":"Bone Res."},{"key":"853_CR306","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s41586-019-1471-1","volume":"572","author":"S Culemann","year":"2019","unstructured":"Culemann, S. et al. Locally renewing resident synovial macrophages provide a protective barrier for the joint. Nature 572, 670\u2013675 (2019).","journal-title":"Nature"},{"key":"853_CR307","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41413-023-00257-w","volume":"11","author":"E Hasco\u00ebt","year":"2023","unstructured":"Hasco\u00ebt, E. et al. New insights into inflammatory osteoclast precursors as therapeutic targets for rheumatoid arthritis and periodontitis. Bone Res. 11, 26 (2023).","journal-title":"Bone Res."},{"key":"853_CR308","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1002\/JPER.17-0721","volume":"89","author":"PN Papapanou","year":"2018","unstructured":"Papapanou, P. N. et al. Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the classification of periodontal and peri-implant diseases and conditions. J. Periodontol. 89, S173\u2013S182 (2018).","journal-title":"J. Periodontol."},{"key":"853_CR309","doi-asserted-by":"publisher","first-page":"479","DOI":"10.5483\/BMBRep.2013.46.10.141","volume":"46","author":"Y Lee","year":"2013","unstructured":"Lee, Y. The role of interleukin-17 in bone metabolism and inflammatory skeletal diseases. BMB Rep. 46, 479\u2013483 (2013).","journal-title":"BMB Rep."},{"key":"853_CR310","doi-asserted-by":"crossref","unstructured":"Jimi, E., Takakura, N., Hiura, F., Nakamura, I. & Hirata-Tsuchiya, S. The role of NF-\u03baB in physiological bone development and inflammatory bone diseases: is NF-\u03baB inhibition \u201cKilling Two Birds with One Stone\u201d. Cells 8, 1636 (2019).","DOI":"10.3390\/cells8121636"},{"key":"853_CR311","doi-asserted-by":"publisher","first-page":"6790","DOI":"10.1074\/jbc.M709909200","volume":"283","author":"LJ Raggatt","year":"2008","unstructured":"Raggatt, L. J. et al. Interleukin-18 is regulated by parathyroid hormone and is required for its bone anabolic actions. J. Biol. Chem. 283, 6790\u20136798 (2008).","journal-title":"J. Biol. Chem."},{"key":"853_CR312","doi-asserted-by":"publisher","first-page":"33098","DOI":"10.1074\/jbc.M611781200","volume":"282","author":"X Li","year":"2007","unstructured":"Li, X. et al. Parathyroid hormone stimulates osteoblastic expression of MCP-1 to recruit and increase the fusion of pre\/osteoclasts. J. Biol. Chem. 282, 33098\u201333106 (2007).","journal-title":"J. Biol. Chem."},{"key":"853_CR313","doi-asserted-by":"crossref","unstructured":"Zhao, B. Does TNF promote or restrain osteoclastogenesis and inflammatory bone resorption? Crit. Rev. Immunol. 38, 253\u2013261 (2018).","DOI":"10.1615\/CritRevImmunol.2018025874"},{"key":"853_CR314","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113139","volume":"42","author":"H Gu","year":"2023","unstructured":"Gu, H. et al. MSU crystal deposition contributes to inflammation and immune responses in gout remission. Cell Rep. 42, 113139 (2023).","journal-title":"Cell Rep."},{"key":"853_CR315","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E24-06-0285","volume":"36","author":"P Chawla","year":"2025","unstructured":"Chawla, P. et al. Breast cancer cells promote osteoclast differentiation in an MRTF-dependent paracrine manner. Mol. Biol. Cell 36, ar8 (2025).","journal-title":"Mol. Biol. Cell"},{"key":"853_CR316","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2024.103189","volume":"145","author":"C Gaudenzi","year":"2024","unstructured":"Gaudenzi, C. et al. Extracellular microRNAs induce dendritic cell-dependent joint inflammation and potentiate osteoclast differentiation via TLR7\/8 engagement. J. Autoimmun. 145, 103189 (2024).","journal-title":"J. Autoimmun."},{"key":"853_CR317","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31475-1","volume":"13","author":"Y Xia","year":"2022","unstructured":"Xia, Y. et al. TGF\u03b2 reprograms TNF stimulation of macrophages towards a non-canonical pathway driving inflammatory osteoclastogenesis. Nat. Commun. 13, 3920 (2022).","journal-title":"Nat. Commun."},{"key":"853_CR318","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1002\/jbmr.502","volume":"26","author":"X Zhang","year":"2011","unstructured":"Zhang, X. et al. The critical role of the epidermal growth factor receptor in endochondral ossification. J. Bone Min. Res. 26, 2622\u20132633 (2011).","journal-title":"J. Bone Min. Res."},{"key":"853_CR319","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27683-w","volume":"13","author":"B Dai","year":"2022","unstructured":"Dai, B. et al. Macrophages in epididymal adipose tissue secrete osteopontin to regulate bone homeostasis. Nat. Commun. 13, 427 (2022).","journal-title":"Nat. Commun."},{"key":"853_CR320","doi-asserted-by":"publisher","first-page":"4452","DOI":"10.4049\/jimmunol.1501466","volume":"196","author":"C Fang","year":"2016","unstructured":"Fang, C. et al. Cutting edge: EZH2 promotes osteoclastogenesis by epigenetic silencing of the negative regulator IRF8. J. Immunol. 196, 4452\u20134456 (2016).","journal-title":"J. Immunol."},{"key":"853_CR321","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.bone.2014.12.060","volume":"74","author":"HJ Cao","year":"2015","unstructured":"Cao, H. J. et al. Src blockage by siRNA inhibits VEGF-induced vascular hyperpemeability and osteoclast activity - an in vitro mechanism study for preventing destructive repair of osteonecrosis. Bone 74, 58\u201368 (2015).","journal-title":"Bone"},{"key":"853_CR322","doi-asserted-by":"crossref","unstructured":"Hadzic, E., To, B., Pest, M. A., Qin, L. & Beier, F. Anabolic phenotype in cartilage-specific mitogen-inducible gene-6 knockout mice is independent of transforming growth factor-\u03b1. Osteoarthr. Cartil. Open 5, 100387 (2023).","DOI":"10.1016\/j.ocarto.2023.100387"},{"key":"853_CR323","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.bone.2006.09.023","volume":"40","author":"M Asagiri","year":"2007","unstructured":"Asagiri, M. & Takayanagi, H. The molecular understanding of osteoclast differentiation. Bone 40, 251\u2013264 (2007).","journal-title":"Bone"},{"key":"853_CR324","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.molmed.2005.11.007","volume":"12","author":"T Wada","year":"2006","unstructured":"Wada, T., Nakashima, T., Hiroshi, N. & Penninger, J. M. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol. Med. 12, 17\u201325 (2006).","journal-title":"Trends Mol. Med."},{"key":"853_CR325","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.ncrna.2024.03.002","volume":"9","author":"Y Sun","year":"2024","unstructured":"Sun, Y., Chen, P. & Zhao, B. Role of extracellular vesicles associated with microRNAs and their interplay with cuproptosis in osteoporosis. Noncoding RNA Res. 9, 715\u2013719 (2024).","journal-title":"Noncoding RNA Res."},{"key":"853_CR326","doi-asserted-by":"publisher","first-page":"421746","DOI":"10.1155\/2015\/421746","volume":"2015","author":"R Florencio-Silva","year":"2015","unstructured":"Florencio-Silva, R., Sasso, G. R., Sasso-Cerri, E., Sim\u00f5es, M. J. & Cerri, P. S. Biology of bone tissue: structure, function, and factors that influence bone cells. Biomed. Res. Int. 2015, 421746 (2015).","journal-title":"Biomed. Res. Int."},{"key":"853_CR327","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1182\/blood-2006-07-037994","volume":"109","author":"Y Li","year":"2007","unstructured":"Li, Y. et al. B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo. Blood 109, 3839\u20133848 (2007).","journal-title":"Blood"},{"key":"853_CR328","doi-asserted-by":"publisher","first-page":"6113","DOI":"10.4049\/jimmunol.161.11.6113","volume":"161","author":"TJ Yun","year":"1998","unstructured":"Yun, T. J. et al. OPG\/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40. J. Immunol. 161, 6113\u20136121 (1998).","journal-title":"J. Immunol."},{"key":"853_CR329","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1073\/pnas.81.7.2181","volume":"81","author":"M Horowitz","year":"1984","unstructured":"Horowitz, M., Vignery, A., Gershon, R. K. & Baron, R. Thymus-derived lymphocytes and their interactions with macrophages are required for the production of osteoclast-activating factor in the mouse. Proc. Natl. Acad. Sci. USA 81, 2181\u20132185 (1984).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"853_CR330","doi-asserted-by":"publisher","first-page":"4231","DOI":"10.4049\/jimmunol.165.8.4231","volume":"165","author":"D Grcevi\u0107","year":"2000","unstructured":"Grcevi\u0107, D., Lee, S. K., Marusi\u0107, A. & Lorenzo, J. A. Depletion of CD4 and CD8 T lymphocytes in mice in vivo enhances 1,25-dihydroxyvitamin D3-stimulated osteoclast-like cell formation in vitro by a mechanism that is dependent on prostaglandin synthesis. J. Immunol. 165, 4231\u20134238 (2000).","journal-title":"J. Immunol."},{"key":"853_CR331","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nrendo.2016.91","volume":"12","author":"MN Weitzmann","year":"2016","unstructured":"Weitzmann, M. N. & Ofotokun, I. Physiological and pathophysiological bone turnover - role of the immune system. Nat. Rev. Endocrinol. 12, 518\u2013532 (2016).","journal-title":"Nat. Rev. Endocrinol."},{"key":"853_CR332","doi-asserted-by":"publisher","first-page":"ra260","DOI":"10.1126\/scitranslmed.3007764","volume":"6","author":"A Bozec","year":"2014","unstructured":"Bozec, A. et al. T cell costimulation molecules CD80\/86 inhibit osteoclast differentiation by inducing the IDO\/tryptophan pathway. Sci. Transl. Med. 6, ra260 (2014).","journal-title":"Sci. Transl. Med."},{"key":"853_CR333","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1136\/ard.2007.080713","volume":"67","author":"R Axmann","year":"2008","unstructured":"Axmann, R. et al. CTLA-4 directly inhibits osteoclast formation. Ann. Rheum. Dis. 67, 1603\u20131609 (2008).","journal-title":"Ann. Rheum. Dis."},{"key":"853_CR334","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3803\/EnM.2023.501","volume":"38","author":"BF Boyce","year":"2023","unstructured":"Boyce, B. F., Li, J., Yao, Z. & Xing, L. Nuclear factor-kappa B regulation of osteoclastogenesis and osteoblastogenesis. Endocrinol. Metab. 38, 504\u2013521 (2023).","journal-title":"Endocrinol. Metab."},{"key":"853_CR335","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s13770-023-00619-9","volume":"21","author":"K Lee","year":"2024","unstructured":"Lee, K., Ko, E. & Park, Y. Adipose tissue-derived mesenchymal stem cell inhibits osteoclast differentiation through tumor necrosis factor stimulated gene-6. Tissue Eng. Regen. Med. 21, 587\u2013594 (2024).","journal-title":"Tissue Eng. Regen. Med."},{"key":"853_CR336","first-page":"55","volume":"39","author":"WY Zhu","year":"2023","unstructured":"Zhu, W. Y. et al. The effect of drug holiday on preventing medication-related osteonecrosis of the jaw in osteoporotic rat model. J. Orthop. Transl. 39, 55\u201362 (2023).","journal-title":"J. Orthop. Transl."},{"key":"853_CR337","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41420-025-02338-7","volume":"11","author":"JH Kim","year":"2025","unstructured":"Kim, J. H. et al. Rac1-dependent regulation of osteoclast and osteoblast differentiation by developmentally regulated GTP-binding 2. Cell Death Discov. 11, 48 (2025).","journal-title":"Cell Death Discov."},{"key":"853_CR338","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.3389\/fimmu.2019.02182","volume":"10","author":"LJ Brylka","year":"2019","unstructured":"Brylka, L. J. & Schinke, T. Chemokines in physiological and pathological bone remodeling. Front. Immunol. 10, 2182 (2019).","journal-title":"Front. Immunol."},{"key":"853_CR339","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/jbmr.199","volume":"26","author":"H Ishizuka","year":"2011","unstructured":"Ishizuka, H. et al. ADAM8 enhances osteoclast precursor fusion and osteoclast formation in vitro and in vivo. J. Bone Min. Res. 26, 169\u2013181 (2011).","journal-title":"J. Bone Min. Res."},{"key":"853_CR340","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.3390\/medicina59091546","volume":"59","author":"S Singh","year":"2023","unstructured":"Singh, S., Sarma, D. K., Verma, V., Nagpal, R. & Kumar, M. From cells to environment: exploring the interplay between factors shaping bone health and disease. Medicina 59, 1546 (2023).","journal-title":"Medicina"},{"key":"853_CR341","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06107-1","volume":"14","author":"X Chen","year":"2023","unstructured":"Chen, X. et al. Dlk2 interacts with Syap1 to activate Akt signaling pathway during osteoclast formation. Cell Death Dis. 14, 589 (2023).","journal-title":"Cell Death Dis."},{"key":"853_CR342","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1007\/s10528-023-10569-5","volume":"62","author":"JH Choi","year":"2024","unstructured":"Choi, J. H. et al. Extracellular vesicles from human adipose tissue-derived mesenchymal stem cells suppress RANKL-induced osteoclast differentiation via miR122-5p. Biochem. Genet. 62, 2830\u20132852 (2024).","journal-title":"Biochem. Genet."},{"key":"853_CR343","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.70028","volume":"13","author":"Q Liu","year":"2024","unstructured":"Liu, Q. et al. Fused extracellular vesicles from M(2) macrophages and human umbilical cord mesenchymal stem cells for the targeted regulation of macrophage pyroptosis in periprosthetic osteolysis. J. Extracell. Vesicles 13, e70028 (2024).","journal-title":"J. Extracell. Vesicles"},{"key":"853_CR344","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1038\/s41418-024-01368-5","volume":"31","author":"Y Shu","year":"2024","unstructured":"Shu, Y. et al. Inhibition of inflammatory osteoclasts accelerates callus remodeling in osteoporotic fractures by enhancing CGRP(+)TrkA(+) signaling. Cell Death Differ. 31, 1695\u20131706 (2024).","journal-title":"Cell Death Differ."},{"key":"853_CR345","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1177\/0022034512468757","volume":"92","author":"B Gao","year":"2013","unstructured":"Gao, B. et al. Inhibiting periapical lesions through AAV-RNAi silencing of cathepsin K. J. Dent. Res. 92, 180\u2013186 (2013).","journal-title":"J. Dent. Res."},{"key":"853_CR346","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1128\/IAI.00756-12","volume":"81","author":"J Ma","year":"2013","unstructured":"Ma, J. et al. RNA interference-mediated silencing of Atp6i prevents both periapical bone erosion and inflammation in the mouse model of endodontic disease. Infect. Immun. 81, 1021\u20131030 (2013).","journal-title":"Infect. Immun."},{"key":"853_CR347","doi-asserted-by":"publisher","first-page":"e0134903","DOI":"10.1371\/journal.pone.0134903","volume":"10","author":"S Li","year":"2015","unstructured":"Li, S. et al. Targeting Atp6v1c1 prevents inflammation and bone erosion caused by periodontitis and reveals its critical function in osteoimmunology. PLoS One 10, e0134903 (2015).","journal-title":"PLoS One"},{"key":"853_CR348","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00436-20","volume":"89","author":"W Yang","year":"2020","unstructured":"Yang, W. et al. Silencing of Ac45 simultaneously inhibits osteoclast-mediated bone resorption and attenuates dendritic cell-mediated inflammation through impairing acidification and cathepsin K secretion. Infect. Immun. 89, e00436-20 (2020).","journal-title":"Infect. Immun."},{"key":"853_CR349","doi-asserted-by":"crossref","unstructured":"Tu, Q. et al. Targeted overexpression of BSP in osteoclasts promotes bone metastasis of breast cancer cells. J. Cell. Physiol. 218, 135\u2013145 (2009).","DOI":"10.1002\/jcp.21576"},{"key":"853_CR350","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1136\/ard-2023-224774","volume":"83","author":"K Kachler","year":"2024","unstructured":"Kachler, K. et al. Acod1-mediated inhibition of aerobic glycolysis suppresses osteoclast differentiation and attenuates bone erosion in arthritis. Ann. Rheum. Dis. 83, 1691\u20131706 (2024).","journal-title":"Ann. Rheum. Dis."},{"key":"853_CR351","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166902","volume":"1870","author":"H Tan","year":"2024","unstructured":"Tan, H. et al. Myo6 mediates osteoclast function and is essential for joint damage in collagen-induced arthritis. Biochim. Biophys. Acta Mol. Basis Dis. 1870, 166902 (2024).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"853_CR352","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10753-023-01914-2","volume":"47","author":"Q Wang","year":"2024","unstructured":"Wang, Q. et al. HSP90 exacerbates bone destruction in rheumatoid arthritis by activating TRAF6\/NFATc1 signaling. Inflammation 47, 363\u2013375 (2024).","journal-title":"Inflammation"},{"key":"853_CR353","first-page":"499","volume":"56","author":"W Chen","year":"2024","unstructured":"Chen, W. et al. Subchondral osteoclasts and osteoarthritis: new insights and potential therapeutic avenues. Acta Biochim. Biophys. Sin. 56, 499\u2013512 (2024).","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"853_CR354","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1038\/cdd.2015.45","volume":"22","author":"X Yuan","year":"2015","unstructured":"Yuan, X. et al. Regulators of G protein signaling 12 promotes osteoclastogenesis in bone remodeling and pathological bone loss. Cell Death Differ. 22, 2046\u20132057 (2015).","journal-title":"Cell Death Differ."},{"key":"853_CR355","doi-asserted-by":"publisher","first-page":"e58599","DOI":"10.1371\/journal.pone.0058599","volume":"8","author":"H Jiang","year":"2013","unstructured":"Jiang, H. et al. RNAi-mediated silencing of Atp6i and Atp6i haploinsufficiency prevents both bone loss and inflammation in a mouse model of periodontal disease. PLoS One 8, e58599 (2013).","journal-title":"PLoS One"},{"key":"853_CR356","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.4049\/jimmunol.161.5.2457","volume":"161","author":"J Melrose","year":"1998","unstructured":"Melrose, J., Tsurushita, N., Liu, G. & Berg, E. L. IFN-gamma inhibits activation-induced expression of E- and P-selectin on endothelial cells. J. Immunol. 161, 2457\u20132464 (1998).","journal-title":"J. Immunol."},{"key":"853_CR357","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/jp.2013.31","volume":"33","author":"K Khozaim","year":"2013","unstructured":"Khozaim, K., Schellinger, M., Cummings, O. & Robinson, B. Peripartum acute liver failure from a vaso-occlusive crisis in a patient with sickle cell trait. J. Perinatol. 33, 654\u2013656 (2013).","journal-title":"J. Perinatol."},{"key":"853_CR358","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1177\/0884533611405673","volume":"26","author":"B Magnuson","year":"2011","unstructured":"Magnuson, B., Peppard, A. & Auer Flomenhoft, D. Hypocaloric considerations in patients with potentially hypometabolic disease States. Nutr. Clin. Pr. 26, 253\u2013260 (2011).","journal-title":"Nutr. Clin. Pr."},{"key":"853_CR359","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/jre.12345","volume":"51","author":"W Chen","year":"2016","unstructured":"Chen, W. et al. The silencing of cathepsin K used in gene therapy for periodontal disease reveals the role of cathepsin K in chronic infection and inflammation. J. Periodontal. Res. 51, 647\u2013660 (2016).","journal-title":"J. Periodontal. Res."},{"key":"853_CR360","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S0092-8674(00)80365-7","volume":"90","author":"M Rubinstein","year":"1997","unstructured":"Rubinstein, M. et al. Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell 90, 991\u20131001 (1997).","journal-title":"Cell"},{"key":"853_CR361","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3389\/fpls.2019.00058","volume":"10","author":"C Wang","year":"2019","unstructured":"Wang, C. et al. The smaller the leaf is, the faster the leaf water loses in a temperate forest. Front. Plant Sci. 10, 58 (2019).","journal-title":"Front. Plant Sci."},{"key":"853_CR362","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.canlet.2019.10.033","volume":"469","author":"Y Guo","year":"2020","unstructured":"Guo, Y. et al. Targeted cancer immunotherapy with genetically engineered oncolytic Salmonella typhimurium. Cancer Lett. 469, 102\u2013110 (2020).","journal-title":"Cancer Lett."},{"key":"853_CR363","doi-asserted-by":"crossref","unstructured":"Ramsey, K. L. et al. The NEF4 complex regulates Rad4 levels and utilizes Snf2\/Swi2-related ATPase activity for nucleotide excision repair. Mol. Cell. Biol. 24, 6362\u20136378 (2004).","DOI":"10.1128\/MCB.24.14.6362-6378.2004"},{"key":"853_CR364","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/72855","volume":"24","author":"K Matsuo","year":"2000","unstructured":"Matsuo, K. et al. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation. Nat. Genet. 24, 184\u2013187 (2000).","journal-title":"Nat. Genet."},{"key":"853_CR365","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1126\/science.7939685","volume":"266","author":"AE Grigoriadis","year":"1994","unstructured":"Grigoriadis, A. E. et al. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266, 443\u2013448 (1994).","journal-title":"Science"},{"key":"853_CR366","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1530\/REP-09-0126","volume":"138","author":"C G\u00f3mez-Fern\u00e1ndez","year":"2009","unstructured":"G\u00f3mez-Fern\u00e1ndez, C. et al. Relocalization of STIM1 in mouse oocytes at fertilization: early involvement of store-operated calcium entry. Reproduction 138, 211\u2013221 (2009).","journal-title":"Reproduction"},{"key":"853_CR367","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1126\/science.286.5445.1738","volume":"286","author":"C Rommel","year":"1999","unstructured":"Rommel, C. et al. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 286, 1738\u20131741 (1999).","journal-title":"Science"},{"key":"853_CR368","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.hlc.2010.09.005","volume":"20","author":"R Duarte","year":"2011","unstructured":"Duarte, R., Fernandez, G., Castellon, D. & Costa, J. C. Prospective coronary CT angiography 128-MDCT versus retrospective 64-MDCT: improved image quality and reduced radiation dose. Heart Lung Circ. 20, 119\u2013125 (2011).","journal-title":"Heart Lung Circ."},{"key":"853_CR369","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1172\/JCI24921","volume":"115","author":"S Bai","year":"2005","unstructured":"Bai, S. et al. FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner. J. Clin. Invest. 115, 2742\u20132751 (2005).","journal-title":"J. Clin. Invest."},{"key":"853_CR370","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/intimm\/dxq431","volume":"22","author":"YM Lee","year":"2010","unstructured":"Lee, Y. M., Fujikado, N., Manaka, H., Yasuda, H. & Iwakura, Y. IL-1 plays an important role in the bone metabolism under physiological conditions. Int. Immunol. 22, 805\u2013816 (2010).","journal-title":"Int. Immunol."},{"key":"853_CR371","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0092-8674(00)81348-3","volume":"87","author":"T Holtschke","year":"1996","unstructured":"Holtschke, T. et al. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 87, 307\u2013317 (1996).","journal-title":"Cell"},{"key":"853_CR372","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1242\/dev.137489","volume":"143","author":"A Houben","year":"2016","unstructured":"Houben, A. et al. \u03b2-catenin activity in late hypertrophic chondrocytes locally orchestrates osteoblastogenesis and osteoclastogenesis. Development 143, 3826\u20133838 (2016).","journal-title":"Development"},{"key":"853_CR373","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1177\/0091270011399576","volume":"52","author":"MM Riggs","year":"2012","unstructured":"Riggs, M. M. et al. Population pharmacokinetics and exposure-response of albinterferon alfa-2b. J. Clin. Pharm. 52, 475\u2013486 (2012).","journal-title":"J. Clin. Pharm."},{"key":"853_CR374","doi-asserted-by":"publisher","first-page":"5482","DOI":"10.1128\/jb.172.9.5482-5485.1990","volume":"172","author":"AM Albertini","year":"1990","unstructured":"Albertini, A. M. & Galizzi, A. The Bacillus subtilis outB gene is highly homologous to an Escherichia coli ntr-like gene. J. Bacteriol. 172, 5482\u20135485 (1990).","journal-title":"J. Bacteriol."},{"key":"853_CR375","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1210\/endo-127-5-2592","volume":"127","author":"R Felix","year":"1990","unstructured":"Felix, R., Cecchini, M. G. & Fleisch, H. Macrophage colony stimulating factor restores in vivo bone resorption in the op\/op osteopetrotic mouse. Endocrinology 127, 2592\u20132594 (1990).","journal-title":"Endocrinology"},{"key":"853_CR376","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/jbmr.5650050716","volume":"5","author":"R Felix","year":"1990","unstructured":"Felix, R. et al. Impairment of macrophage colony-stimulating factor production and lack of resident bone marrow macrophages in the osteopetrotic op\/op mouse. J. Bone Min. Res. 5, 781\u2013789 (1990).","journal-title":"J. Bone Min. Res."},{"key":"853_CR377","doi-asserted-by":"publisher","first-page":"4828","DOI":"10.1073\/pnas.87.12.4828","volume":"87","author":"W Wiktor-Jedrzejczak","year":"1990","unstructured":"Wiktor-Jedrzejczak, W. et al. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op\/op) mouse. Proc. Natl. Acad. Sci. USA 87, 4828\u20134832 (1990).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"853_CR378","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.638144","volume":"12","author":"S Munusamy Ponnan","year":"2021","unstructured":"Munusamy Ponnan, S. et al. Elevated numbers of HIV-specific poly-functional CD8(+) T cells with stem cell-like and follicular homing phenotypes in HIV-exposed seronegative individuals. Front. Immunol. 12, 638144 (2021).","journal-title":"Front. Immunol."},{"key":"853_CR379","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1006\/dbio.2001.0391","volume":"238","author":"R Zent","year":"2001","unstructured":"Zent, R. et al. Involvement of laminin binding integrins and laminin-5 in branching morphogenesis of the ureteric bud during kidney development. Dev. Biol. 238, 289\u2013302 (2001).","journal-title":"Dev. Biol."},{"key":"853_CR380","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1136\/hrt.71.6.515","volume":"71","author":"J Nolan","year":"1994","unstructured":"Nolan, J. et al. Cardiac parasympathetic activity in severe uncomplicated coronary artery disease. Br. Heart J. 71, 515\u2013520 (1994).","journal-title":"Br. Heart J."},{"key":"853_CR381","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antib9010001","volume":"9","author":"M Paul","year":"2020","unstructured":"Paul, M. & Weller, M. G. Antibody screening by microarray technology-direct identification of selective high-affinity clones. Antibodies 9, 1 (2020).","journal-title":"Antibodies"},{"key":"853_CR382","doi-asserted-by":"crossref","unstructured":"Djalilian, A. R. et al. Connexin 26 regulates epidermal barrier and wound remodeling and promotes psoriasiform response. J. Clin. Invest. 116, 1243\u20131253 (2006).","DOI":"10.1172\/JCI27186"},{"key":"853_CR383","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/415180a","volume":"415","author":"Y Ho","year":"2002","unstructured":"Ho, Y. et al. Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature 415, 180\u2013183 (2002).","journal-title":"Nature"},{"key":"853_CR384","doi-asserted-by":"publisher","first-page":"3890","DOI":"10.1210\/en.2008-0140","volume":"149","author":"S Zanotti","year":"2008","unstructured":"Zanotti, S. et al. Notch inhibits osteoblast differentiation and causes osteopenia. Endocrinology 149, 3890\u20133899 (2008).","journal-title":"Endocrinology"},{"key":"853_CR385","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/S0092-8674(00)80275-5","volume":"89","author":"H Masai","year":"1997","unstructured":"Masai, H. & Arai, K. Frpo: a novel single-stranded DNA promoter for transcription and for primer RNA synthesis of DNA replication. Cell 89, 897\u2013907 (1997).","journal-title":"Cell"},{"key":"853_CR386","doi-asserted-by":"crossref","unstructured":"Eckmann, L. et al. Role of intestinal epithelial cells in the host secretory response to infection by invasive bacteria. Bacterial entry induces epithelial prostaglandin h synthase-2 expression and prostaglandin E2 and F2alpha production. J. Clin. Invest. 100, 296\u2013309 (1997).","DOI":"10.1172\/JCI119535"},{"key":"853_CR387","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1101\/gad.11.24.3482","volume":"11","author":"G Franzoso","year":"1997","unstructured":"Franzoso, G. et al. Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev. 11, 3482\u20133496 (1997).","journal-title":"Genes Dev."},{"key":"853_CR388","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41371-020-0323-7","volume":"34","author":"CLB Ho","year":"2020","unstructured":"Ho, C. L. B. et al. Legacy effect of delayed blood pressure lowering drug treatment in middle-aged adults with mildly elevated blood pressure: systematic review and meta-analysis. J. Hum. Hypertens. 34, 261\u2013270 (2020).","journal-title":"J. Hum. Hypertens."},{"key":"853_CR389","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nsmb953","volume":"12","author":"Z Lou","year":"2005","unstructured":"Lou, Z., Minter-Dykhouse, K. & Chen, J. BRCA1 participates in DNA decatenation. Nat. Struct. Mol. Biol. 12, 589\u2013593 (2005).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"853_CR390","doi-asserted-by":"publisher","first-page":"6729","DOI":"10.1523\/JNEUROSCI.17-17-06729.1997","volume":"17","author":"CT Dickson","year":"1997","unstructured":"Dickson, C. T. & Alonso, A. Muscarinic induction of synchronous population activity in the entorhinal cortex. J. Neurosci. 17, 6729\u20136744 (1997).","journal-title":"J. Neurosci."},{"key":"853_CR391","doi-asserted-by":"publisher","first-page":"5647","DOI":"10.1002\/j.1460-2075.1996.tb00949.x","volume":"15","author":"SR McKercher","year":"1996","unstructured":"McKercher, S. R. et al. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15, 5647\u20135658 (1996).","journal-title":"EMBO J."},{"key":"853_CR392","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jchromb.2008.01.045","volume":"864","author":"J Xie","year":"2008","unstructured":"Xie, J., Ding, C., Ge, Q., Zhou, Z. & Zhi, X. Simultaneous determination of ginkgolides A, B, C and bilobalide in plasma by LC-MS\/MS and its application to the pharmacokinetic study of Ginkgo biloba extract in rats. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 864, 87\u201394 (2008).","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"853_CR393","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0952-7915(03)00050-5","volume":"15","author":"MM Winslow","year":"2003","unstructured":"Winslow, M. M., Neilson, J. R. & Crabtree, G. R. Calcium signalling in lymphocytes. Curr. Opin. Immunol. 15, 299\u2013307 (2003).","journal-title":"Curr. Opin. Immunol."},{"key":"853_CR394","doi-asserted-by":"crossref","unstructured":"Lee, H. K., Yoo, M. S., Choi, H. S., Kwon, H. B. & Soh, J. Retinoic acids up-regulate steroidogenic acute regulatory protein gene. Mol. Cell. Endocrinol. 148, 1\u201310 (1999).","DOI":"10.1016\/S0303-7207(98)00243-3"},{"key":"853_CR395","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S0028-3908(98)00229-9","volume":"38","author":"R Schnabel","year":"1999","unstructured":"Schnabel, R., Palmer, M. J., Kilpatrick, I. C. & Collingridge, G. L. A CaMKII inhibitor, KN-62, facilitates DHPG-induced LTD in the CA1 region of the hippocampus. Neuropharmacology 38, 605\u2013608 (1999).","journal-title":"Neuropharmacology"},{"key":"853_CR396","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.4103\/1319-2442.243953","volume":"29","author":"PS Sarvepalli","year":"2018","unstructured":"Sarvepalli, P. S. et al. Study of therapeutic efficacy of febuxostat in chronic kidney disease stage IIIA to stage VD. Saudi J. Kidney Dis. Transpl. 29, 1050\u20131056 (2018).","journal-title":"Saudi J. Kidney Dis. Transpl."},{"key":"853_CR397","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.arthro.2019.10.011","volume":"36","author":"J Rabinowitz","year":"2020","unstructured":"Rabinowitz, J. et al. The effect of screw design and cortical augmentation on insertional torque and compression in coracoid-glenoid fixation in a sawbones model. Arthroscopy 36, 689\u2013695 (2020).","journal-title":"Arthroscopy"},{"key":"853_CR398","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/hmg\/ddm288","volume":"17","author":"SV Dindot","year":"2008","unstructured":"Dindot, S. V., Antalffy, B. A., Bhattacharjee, M. B. & Beaudet, A. L. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology. Hum. Mol. Genet. 17, 111\u2013118 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"853_CR399","doi-asserted-by":"publisher","first-page":"267","DOI":"10.4248\/BR201303005","volume":"1","author":"S Yang","year":"2013","unstructured":"Yang, S. et al. Inhibition of Rgs10 expression prevents immune cell infiltration in bacteria-induced inflammatory lesions and osteoclast-mediated bone destruction. Bone Res. 1, 267\u2013281 (2013).","journal-title":"Bone Res."},{"key":"853_CR400","doi-asserted-by":"crossref","unstructured":"de Lonlay, P. et al. A mutant mitochondrial respiratory chain assembly protein causes complex III deficiency in patients with tubulopathy, encephalopathy and liver failure. Nat. Genet. 29, 57\u201360 (2001).","DOI":"10.1038\/ng706"},{"key":"853_CR401","unstructured":"Sly, W. S. & Shah, G. N. The carbonic anhydrase II deficiency syndrome: osteopetrosis with renal tubular acidosis and cerebral calcification. In The Online Metabolic and Molecular Bases of Inherited Disease. (eds. D. L. Valle, S. Antonarakis, A. Ballabio, A. L. Beaudet & G. A. Mitchell) (McGraw-Hill Education, 2019)."},{"key":"853_CR402","first-page":"447","volume":"20","author":"GJ Schwartz","year":"1991","unstructured":"Schwartz, G. J., Brion, L. P., Corey, H. E. & Dorfman, H. D. Case report 668. Carbonic anhydrase II deficiency syndrome (osteopetrosis associated with renal tubular acidosis and cerebral calcification). Skelet. Radio. 20, 447\u2013452 (1991).","journal-title":"Skelet. Radio."},{"key":"853_CR403","doi-asserted-by":"crossref","unstructured":"Lehenkari, P., Hentunen, T. A., Laitala-Leinonen, T., Tuukkanen, J. & V\u00e4\u00e4n\u00e4nen, H. K. Carbonic anhydrase II plays a major role in osteoclast differentiation and bone resorption by effecting the steady state intracellular pH and Ca2+. Exp. Cell Res. 242, 128\u2013137 (1998).","DOI":"10.1006\/excr.1998.4071"},{"key":"853_CR404","first-page":"5030","volume":"19","author":"L Li","year":"2019","unstructured":"Li, L., Lv, S. S., Wang, C., Yue, H. & Zhang, Z. L. Novel CLCN7 mutations cause autosomal dominant osteopetrosis type II and intermediate autosomal recessive osteopetrosis. Mol. Med. Rep. 19, 5030\u20135038 (2019).","journal-title":"Mol. Med. Rep."},{"key":"853_CR405","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1210\/jc.2006-1986","volume":"92","author":"SG Waguespack","year":"2007","unstructured":"Waguespack, S. G., Hui, S. L., Dimeglio, L. A. & Econs, M. J. Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation. J. Clin. Endocrinol. Metab. 92, 771\u2013778 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"853_CR406","doi-asserted-by":"publisher","first-page":"599826","DOI":"10.3389\/fcell.2020.599826","volume":"8","author":"H Peng","year":"2020","unstructured":"Peng, H., He, H. B. & Wen, T. A novel variant in CLCN7 regulates the coupling of angiogenesis and osteogenesis. Front. Cell Dev. Biol. 8, 599826 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"853_CR407","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1093\/hmg\/10.25.2861","volume":"10","author":"E Cleiren","year":"2001","unstructured":"Cleiren, E. et al. Albers-Sch\u00f6nberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene. Hum. Mol. Genet. 10, 2861\u20132867 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"853_CR408","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1074\/jbc.M608572200","volume":"282","author":"NA Meadows","year":"2007","unstructured":"Meadows, N. A. et al. The expression of Clcn7 and Ostm1 in osteoclasts is coregulated by microphthalmia transcription factor. J. Biol. Chem. 282, 1891\u20131904 (2007).","journal-title":"J. Biol. Chem."},{"key":"853_CR409","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/hep.510260234","volume":"26","author":"HH Feucht","year":"1997","unstructured":"Feucht, H. H. et al. Distribution of hepatitis G viremia and antibody response to recombinant proteins with special regard to risk factors in 709 patients. Hepatology 26, 491\u2013494 (1997).","journal-title":"Hepatology"},{"key":"853_CR410","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0277-9536(99)00444-X","volume":"51","author":"WC Cockerham","year":"2000","unstructured":"Cockerham, W. C., Hattori, H. & Yamori, Y. The social gradient in life expectancy: the contrary case of Okinawa in Japan. Soc. Sci. Med. 51, 115\u2013122 (2000).","journal-title":"Soc. Sci. Med."},{"key":"853_CR411","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1073\/pnas.98.2.404","volume":"98","author":"ME Newman","year":"2001","unstructured":"Newman, M. E. The structure of scientific collaboration networks. Proc. Natl. Acad. Sci. USA 98, 404\u2013409 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"853_CR412","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nm842","volume":"9","author":"N Chalhoub","year":"2003","unstructured":"Chalhoub, N. et al. Grey-lethal mutation induces severe malignant autosomal recessive osteopetrosis in mouse and human. Nat. Med. 9, 399\u2013406 (2003).","journal-title":"Nat. Med."},{"key":"853_CR413","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1006\/geno.1999.6032","volume":"62","author":"J G\u00e9cz","year":"1999","unstructured":"G\u00e9cz, J. et al. Characterization of the human glutamate receptor subunit 3 gene (GRIA3), a candidate for bipolar disorder and nonspecific X-linked mental retardation. Genomics 62, 356\u2013368 (1999).","journal-title":"Genomics"},{"key":"853_CR414","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/35053124","volume":"409","author":"KM Dohoney","year":"2001","unstructured":"Dohoney, K. M. & Gelles, J. Chi-sequence recognition and DNA translocation by single RecBCD helicase\/nuclease molecules. Nature 409, 370\u2013374 (2001).","journal-title":"Nature"},{"key":"853_CR415","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1002\/jbmr.1849","volume":"28","author":"A Pangrazio","year":"2013","unstructured":"Pangrazio, A. et al. SNX10 mutations define a subgroup of human autosomal recessive osteopetrosis with variable clinical severity. J. Bone Min. Res. 28, 1041\u20131049 (2013).","journal-title":"J. Bone Min. Res."},{"key":"853_CR416","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1086\/340847","volume":"70","author":"M Tartaglia","year":"2002","unstructured":"Tartaglia, M. et al. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am. J. Hum. Genet. 70, 1555\u20131563 (2002).","journal-title":"Am. J. Hum. Genet."},{"key":"853_CR417","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1172\/JCI30328","volume":"117","author":"L Van Wesenbeeck","year":"2007","unstructured":"Van Wesenbeeck, L. et al. Involvement of PLEKHM1 in osteoclastic vesicular transport and osteopetrosis in incisors absent rats and humans. J. Clin. Invest. 117, 919\u2013930 (2007).","journal-title":"J. Clin. Invest."},{"key":"853_CR418","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/cne.903390111","volume":"339","author":"BT Himes","year":"1994","unstructured":"Himes, B. T., Goldberger, M. E. & Tessler, A. Grafts of fetal central nervous system tissue rescue axotomized Clarke\u2019s nucleus neurons in adult and neonatal operates. J. Comp. Neurol. 339, 117\u2013131 (1994).","journal-title":"J. Comp. Neurol."},{"key":"853_CR419","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/jbmr.464","volume":"26","author":"T Yasui","year":"2011","unstructured":"Yasui, T. et al. Epigenetic regulation of osteoclast differentiation: possible involvement of Jmjd3 in the histone demethylation of Nfatc1. J. Bone Min. Res. 26, 2665\u20132671 (2011).","journal-title":"J. Bone Min. Res."},{"key":"853_CR420","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1111\/odi.14160","volume":"29","author":"R Wang","year":"2023","unstructured":"Wang, R. et al. Osteoblast Jmjd3 regulates osteoclastogenesis via EphB4 and RANKL signalling. Oral. Dis. 29, 1613\u20131621 (2023).","journal-title":"Oral. Dis."},{"key":"853_CR421","doi-asserted-by":"publisher","first-page":"12056","DOI":"10.1074\/jbc.M110.216853","volume":"286","author":"L Pham","year":"2011","unstructured":"Pham, L. et al. HDAC3 and HDAC7 have opposite effects on osteoclast differentiation. J. Biol. Chem. 286, 12056\u201312065 (2011).","journal-title":"J. Biol. Chem."},{"key":"853_CR422","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13072-019-0270-0","volume":"12","author":"Y Shin","year":"2019","unstructured":"Shin, Y. et al. DNMT and HDAC inhibitors modulate MMP-9-dependent H3 N-terminal tail proteolysis and osteoclastogenesis. Epigenet. Chromatin 12, 25 (2019).","journal-title":"Epigenet. Chromatin"},{"key":"853_CR423","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.bbrc.2018.10.025","volume":"505","author":"ZY Jiang","year":"2018","unstructured":"Jiang, Z. Y. et al. Downregulation of miR-223 and miR-19a induces differentiation and promotes recruitment of osteoclast cells in giant-cell tumor of the bone via the Runx2\/TWIST-RANK\/RANKL pathway. Biochem. Biophys. Res. Commun. 505, 1003\u20131009 (2018).","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Cell Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41421-025-00853-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41421-025-00853-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41421-025-00853-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T17:04:10Z","timestamp":1768928650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41421-025-00853-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":423,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["853"],"URL":"https:\/\/doi.org\/10.1038\/s41421-025-00853-6","relation":{},"ISSN":["2056-5968"],"issn-type":[{"value":"2056-5968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"assertion":[{"value":"24 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"6"}}